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                                                           ABSTRACT 
Association between CD4+T lymphocyte levels and “red complex” 
pathogens of Chronic Inflammatory Periodontal disease in HIV-positive 
patients 
C. N. John 
MSc minithesis. Department of Oral Medicine and Periodontics, University of the 
Western Cape 
Background: Infection with HIV results in gradual loss of immunologic functions, especially 
those mediated by CD4+T helper cells with consequent impairment of the immune response 
leading to severe manifestations of periodontal disease. The lower the CD4+T lymphocyte 
cell count or the higher the level of immunosuppression, the higher the incidence of 
periodontal disease in those patients will be. Putative periodontopathic bacteria namely 
Porphyromonas gingivalis, Treponema denticola and Tannerella forsythia, commonly 
referred to as “red complex”, and many other bacterial species have been implicated in the 
initiation and progression of periodontal disease. Objective: The present study tests the 
association between different CD4+T lymphocyte levels and “red complex” pathogens using 
BANA, in HIV-positive patients with chronic inflammatory periodontal disease (CIPD). 
Methods: 120 HIV-positive patients from the infectious disease clinic at Tygerberg hospital 
participated in the study with a mean age of 33.3 years.  The CD4+T lymphocyte counts were 
obtained from patient’s medical records. The six Ramjford teeth were used for evaluating 
periodontal clinical parameters such as plaque index, gingival index, periodontal probing 
depth and clinical attachment loss. Subgingival plaque samples were collected and analyzed 
by the enzymatic BANA test for the detection of the “red complex”.  
Results: The CD4+T lymphocyte mean level was 293.43cells/mm
3
.Statistically significant 
associations were found between CD4+T cell counts and probing depth (p= 0.0434) and 
clinical attachment loss (p= 0.0268). Significant associations were found between BANA 
with all the clinical indices (p= <0.05). However no association was found between CD4+T 
cell counts and BANA. Conclusion: HIV-positive patients show a high prevalence of “red 
complex” pathogens subgingivally. Immunosuppression seems to favour the colonization of 
these species, resulting in periodontal disease manifestations. 
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1: LITERATURE REVIEW 
 
1:1 INTRODUCTION 
According to the World Health Report in 1996, a global crisis exists across the world in 
respect to infectious diseases. Among the infectious diseases, human immunodeficiency virus 
infection, which eventually results in AIDS, remains as a global health problem. The Sub-
Saharan African populations account for about 70% of the World’s total bulk of HIV-infected 
individuals and AIDS patients (WHO, 1996 a).  HIV infection is characterized by the decline 
of CD4+T lymphocytes, thus lowering the immune status of the patients.  
 
Periodontal disease has been associated with HIV (Holmstrup, 1994). The presence and 
severity of periodontal disease may be considered as one of the first clinical presentations of 
a previously undiagnosed HIV infection (Howard, 1991). Periodontal disease is an 
inflammatory disease with a multifactorial etiology. Inadequate oral hygiene and a decrease 
in CD4+T lymphocyte cell count results in plaque formation and ultimately, periodontal 
inflammation with destruction of the supporting tooth structures (Kroidl, 2005).  Microbial 
complexes of subgingival plaque in HIV-positive patients with periodontal disease have been 
studied (Aas et al, 2007; Goncalves et al, 2007) and more than 500 bacterial species are 
capable of colonizing the oral cavity (Socransky, 1998; Wilson, 1997; Kolenbrander, 1995).  
A literature search identified more than 383 publications regarding the relationship between 
periodontal disease and HIV infection between 1986 and June 2000, and yet this area of 
research remains poorly understood (Robinson, 2002).  The progression of HIV infection and 
the severity of periodontal inflammation and subsequent destruction of the periodontium have 
been clearly demonstrated (Drinkard, 1991) with a recent study reporting an increased risk of 
dental and periodontal disease in HIV-positive and AIDS patients among American Indian 
and Alaska Natives when compared with the general population (Goddard et al, 2005). 
Moreover, many studies have also related the degree of immunosuppression and HIV viral 
load to the progression of periodontal disease (McDonell, 1990; Mellors, 1997) and proposed 
that the increased number of mast cells, macrophages and neutrophils in chronic periodontitis 
may release inflammatory mediators causing loss of periodontal tissue and severe destruction 
of the periodontium in HIV-positive individuals (Myint et al, 2002).  However; several other 
studies do not indicate a strong association between the periodontal condition and HIV 
infection (Martinez-Canut et al, 1996; Smith et al, 1995; Tomar et al, 1995; Doshi et al 2008; 
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Goncalves, 2005 a).  The purpose of the current study was to investigate the presence of 
subgingival “red complex” periodontal pathogens in HIV-positive patients, with clinical 
indices used in the diagnosis of chronic inflammatory periodontal disease at various CD4+T 
lymphocyte levels.  
1:2 AETIOLOGY AND PATHOGENESIS OF PERIODONTAL DISEASES 
The primary aetiology of periodontal diseases is the formation and adhesion of dental plaque 
on the surfaces of the tooth (Carranza, 2009 a). Dental plaque can be defined as the diverse 
community of micro-organisms found on the tooth surface as a biofilm, embedded in an 
extracellular matrix of polymers of host and microbial origin (Marsh, 2004 a). The dental 
plaque biofilm develops under different conditions and environments. According to recent 
studies, dental plaque consists of at least 800 bacterial species (Aas et al, 2005, 2008; Preza 
et al, 2008; Paster et al, 2006). Formation of plaque involves three major phases: (1) pellicle 
formation on the tooth surface, (2) initial adhesion and bacterial attachment, (3) colonization 
and plaque maturation. The pellicle consists of glycoproteins, phosphoproteins and enzymes.  
The mechanism involved in enamel pellicle formation includes electrostatic, van der Waals 
and hydrostatic forces. Transport of the bacteria to the tooth surface takes place by Brownian 
motion and initial adhesion is by the electrostatic bonding between the host receptors and 
bacterial adhesins (fimbriae). The bacteria from the pellicle undergo proliferation to form 
colonies and co-aggregation of bacteria contributing to the complexity and composition of 
dental plaque formation (Filoche, 2010). 
Dental plaque is classified according to location into supragingival and subgingival plaque 
(Carranza, 1997 b). Supragingival plaque is a thick, non-calcified mass of plaque found at or 
above the gingival margin and consists predominantly of Gram-positive saccharolytic 
bacterial flora, which are cariogenic. Subgingival plaque is located entirely within the 
gingival sulcus or periodontal pocket, and is mainly composed of proteolytic Gram-negative 
bacterial microflora responsible for periodontal diseases (Slots, 1992; Genco, 1990). Hence 
dental plaque can be considered as an aetiologic agent for both dental caries and periodontal 
diseases (Marsh, 2006 b).  
The periodontium serves as a reservoir for microorganisms. The first microscopic 
examination of the complexity of subgingival microbiota was recognized by Van 
Leeuwenhoek in 1683 (Tal, 1980). Inadequate oral hygiene, leads to the accumulation of 
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bacteria in the gingival crevice and with the gradual increase in the proportions of Gram-
negative, anaerobic periodontopathogens there is a gradual progression to periodontal 
infections. Evidence in the literature indicates that the destructive process begins with biofilm 
accumulations that contain bacterial masses in the range of 1 to 2×10
11 
bacteria per gram at or 
below the gingival margins (Gibbons, 1980). The destruction proceeds with the release of 
toxic products such as lipopolysaccharides (LPS) and hydrolytic enzymes, from the 
pathogenic plaque bacteria (AAP, 1998 b). LPS induce the release of proinflammatory 
cytokines such as tumour necrosis factor-alpha (TNF-α) and interleukin-1 beta (IL-1β) which 
may enter the blood stream and trigger the induction of systemic inflammatory responses 
(Yiorgos, 2006).  
Dental plaque becomes mineralized from mineral components of saliva and becomes 
calculus. The rough surface of calculus provides an ideal medium for further plaque growth, 
threatening the health of gingiva (Lindhe, 2008). The understanding of the aetiology and 
pathogenesis of periodontal disease has remarkably changed over the last 30 years (Page, 
1998). At the 1996 World Workshop, it was concluded that most of the human periodontitis 
is caused by Porphyromonas gingivalis, Tannerella forsythia, Aggregatibacter 
actinomycetemcomitans (earlier named as Actinobacillus actinomycetemcomitans) 
(Consensus Report, 1996). There are other species in the mouth which in most of the cases 
are the primary pathogens causing periodontal disease, but they act indirectly in the 
progression of periodontal disease. A diverse group of Gram-negative species coaggreggate 
with the initial primary colonizers such as the streptococci, with minor proportions of 
Actinomyces, Gemella, Neisseria, Rothia and Veillonella species. The succession of bacterial 
colonization influences plaque maturation leading to the establishment of periodontal 
pathogens depending on the increase in bacterial diversity over time (Kolenbrander et al, 
2006). On day one of plaque formation, Actinomyces species show unusually high 
proportions followed by Fusobacterium nucleatum on day four of plaque development, which 
in turn coaggregates with several late colonizers. In moderately deep pockets, the surface 
layers of subgingival plaque are inhabited by Treponema denticola while Porphyromonas 
gingivalis is predominantly restricted to the inner layers. However, both bacterial species co-
exist in deeper pockets (Kigure et al, 1995). Fusobacterium nucleatum releases fatty acids 
which are required for the growth and metabolism of Treponema denticola (Miyakawa and 
Nakazawa, 2010) and also provides nutrional requirements for Tannerella forsythia (Tanner, 
1986). Apparently, Fusobacterium nucleatum facilitates nutrional interdependence with other 
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oral microorganisms and coaggregates with all other oral bacteria (Whittaker, 1996) and 
should therefore be considered as an important contributor for the oral biofilm formation. 
Periodontal pathogens are essential but not sufficient to initiate the destruction of the 
periodontium (van Winkelhoff, 2002). The susceptibility of the host in the initiation and 
progression of the disease is also an important factor. The virulence of microorganisms 
depends on its ability to invade and grow within a susceptible host. The inflammatory host 
response to the periodontal pathogens leads to clinical manifestation of the disease (Kinane, 
2001 a).  Experimental evidence indicates that any shift in the T cell immune response leads 
to periodontal disease progression (Geatch et al, 1997; Preshaw et al, 1998; Seymour et al, 
1993). For the progression of periodontitis into an advanced disease, both immune and 
inflammatory responses are essential and are confounded by various intrinsic (eg: genetics) 
and induced (eg: pollutants) host-related factors (Page and Kornman, 1997; Offenbacher, 
1996; Taubman et al, 2007). These environmental responses lead to the bacterial succession 
favouring the ecological plaque hypothesis. The ecological shifts in the environment are 
responsible for the pathogenecity and virulence factors of the bacterial species (Marsh, 1991 
c). According to the ecological plaque hypothesis, periodontal disease is an opportunistic 
endogenous infection brought about by an ecological shift in the plaque biofilm from a 
predominantly Gram-positive facultatively anaerobic microflora to a Gram-negative obligate 
anaerobic or micro-aerophilic flora, resulting from host-microbial and microbe-microbe 
interactions, creating an anaerobic environment which favours their growth (Konopka, 2006). 
With synergy prevailing over antagonism, the oral microbial species in the dental plaque 
respond to the ecological changes and react as a single unit rather than as individual species 
(Caldwell et al, 1997). A relationship exists between the community members of the oral 
microbiota favouring the formation of the plaque biofilm (Dawes, 2008; Mineoka et al, 
2008).  
 
Dental plaque is initially composed of Gram-positive cocci which are gradually replaced by 
Gram-positive filamentous forms of microorganisms followed by an abundance of Gram-
negative colonisation of microorganisms in the gingival sulcus (Kolenbrander et al, 1985). 
Approximately 1,200 predominant species in the oral cavity were revealed in an analysis of 
more than 36,000 16Sr DNA gene clones (Dewhirst et al, 2010). Cooperative and 
competitive mmunity interactions among the oral bacteria may influence metabolic 
communication; as for example, the release of vitamin K by the Veillonella species supports 
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the growth of Prevotella and Porphyromonas species (Hojo et al, 2009). The specific 
interactions among the oral bacteria in the form of co-aggregates have been considered 
responsible for the development of oral biofilms (Kolenbrander, 2000). Coaggregation can be 
intrageneric, intergeneric or multigeneric cell-to-cell recognition (Kolenbrander, 1989 a) and 
is achieved by the colonisation of a synergestic species. Intergeneric coaggregations are 
found between Fusobacterium and other bacteria such as Aggregatibacter 
actinomycetemcomitans (Rosen et al, 2003), Tannerella forsythia (Sharma et al, 2005), and 
oral Treponema species (Kolenbrander et al, 1995). Intrageneric coaggregations are found 
among different strains of oral fusobacteria (Kolenbrander et al, 1995), Porphyromonas 
gingivalis (Lamont et al, 1992), oral streptococci, and Actinomyces species (Kolenbrander 
and Andersson, 1989 b). Herpes viruses such as Epstein-Barr virus-1 (EBV-1) and 
Cytomegalovirus (CMV) may also influence the pathogenesis of chronic periodontitis 
facilitating synergistic mechanisms with Aggregatibacter actinomycetemcomitans, 
Porphyromonas gingivalis and Tannerella forsythia (Chalabi et al, 2010; Dawson et al, 2009; 
Slots, 2010 a). Loss of epithelial attachment and adult periodontitis is associated with a 
consortium of bacteria (Moore, 1994; Darveau et al, 1997) or more likey several clonal types 
of subgingival pathogens rather than one species. Aggregatibacter actinomycetemcomitans 
(Sreenivasan, 1993) and Porphyromonas gingivalis (Duncan et al, 1993; Lamont et al, 1995) 
invade gingival epithelial cells and mediate extensive tissue destruction. 
 
1:3 CHRONIC INFLAMMATORY PERIODONTAL DISEASES- GINGIVITIS AND 
PERIODONTITIS 
Gingivitis and periodontitis are inflammatory and immunological reactions to the dental 
plaque or oral biofilm, composed of predominantly Gram-negative anaerobic microorganisms 
(Grossi, 1994). The initial inflammatory reaction is known as gingivitis and is limited to the 
gingiva without affecting the deeper connective tissue attachment. In advanced lesions, 
gingivitis may lead to the destruction of the connective tissue attachment and underlying 
alveolar bone resulting in periodontitis (Tucker, 2006).  By definition, gingivitis is the result 
of a non-specific inflammatory reaction response to an increase in the mass of bacteria (either 
Gram-negative or Gram-positive) at or under the gingival crevice (Darveau et al, 1997) and 
periodontitis appears to be an inflammatory disease of specific bacterial origin 
(predominantly Gram-negative) (AAP, 2001 a).  Gram-negative anaerobes predominate as 
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gingivitis and periodontitis progress clinically (Slots, 1979 b). An advanced and established 
periodontal disease can cause pain and tooth mobility due to a high degree of alveolar bone 
loss. Tooth loss may be the ultimate consequence of destructive periodontal disease, leading 
to impaired function and changes in facial appearance. 
Gingivitis is caused  by dental plaque which is the most common cause of gingival disease, or 
it can be of non-plaque origin, including gingival lesions due to bacterial, viral, fungal, 
genetic or systemic conditions (Lindhe, 2008). Non-plaque induced gingivitis may be 
induced by microorganisms such as Treponema pallidum, Neisseria gonorrhoeae, 
streptococci, herpesviruses and oral Candida species (Armitage, 1999). According to the 
clinical observations and scientific research compiled by Marsh and Martin (2000) as well as 
Liebana (2002), periodontitis is classified according to the extent of lesions (localized or 
generalized), rate of progress (slow, rapid and chronic), and the age of onset in affected 
individuals (aggressive and chronic).  
1:4 PREVALENCE OF PERIODONTAL DISEASE 
Depending on the diagnostic criteria, periodontal disease is one of the most ubiquitous 
diseases with a reported prevalence varying between 10% and 60% in adults (Albandar, 
2002; Offenbacher, 2001). The prevalence of periodontal disease increases with age 
(Loesche, 2001) but recently this concept has been challenged and it is considered that with a 
proper oral hygiene maintenance, periodontal disease can be prevented (Lindhe, 2008). 
According to the data published in 1996 World Workshop in Periodontics, advanced adult 
periodontitis does not exceed a prevalence of 10-15% in most populations (Papapanou, 1999 
a). About 75-80% of the individuals show varying degrees of susceptibility to periodontal 
diseases. In addition, about 10% of the population appears to be completely resistant, despite 
the presence of plaque, and the reason for this is not known (Tucker, 2006) 
1:5 MICROBIAL COMPLEXES IN SUBGINGIVAL PLAQUE 
As previously mentioned, periodontal disease is initiated by the overgrowth of certain Gram-
negative, anaerobic bacteria growing in subgingival areas. The bacterial species associated 
with periodontal disease are harboured within the dental plaque or oral biofilm both above 
and below the gum margins. In 1998, Socransky and colleagues examined over 13,000 
subgingival plaque samples using cluster analysis, and divided these bacteria into clusters or 
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microbial complexes, with colour designation assigned for each complex (Table.1).  Each 
cluster was created based on similarities and differences in nutritional and atmospheric 
environments and was considered to influence other clusters, in addition to being related to a 
specific periodontal state, indicating that these microbes are very closely associated with one 
another (Sbordone, 2003; Socransky, 2000). The “blue”, “green”, “yellow” and “purple” 
complexes were considered as early plaque colonisers. As the biofilm matures, organisms of 
the “orange” complex appear which are required for the subsequent colonisation of the more 
pathogenic “red” complex. The “orange” and “red” complex bacterial species are considered 
to be the major etiologic agents of periodontal diseases (Socransky, 1998). Furthermore, 
microbial species found in the “red” cluster were rarely observed without the presence of the 
“orange” cluster species, showing a great deal of inter-species communication (Socransky, 
2000). The “orange” complex microorganisms were associated with pocket depth but less 
frequently related with the other clinical parameters of periodontal disease, while the 
“purple”, “yellow” and “green” complexes were considered to be more strongly associated 
with each other than with either the “red” or “orange” complexes, suggesting a possible 
pattern or sequence of microbial colonization (Feres et al, 2004).  
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Table 1: Bacterial clusters described by Socransky et al (1998) 
                      Complex                     Bacterial cluster 
  Red Porphyromonas gingivalis, Treponema denticola, 
Tannerella  forsythia 
                      
                       Orange 
Fusobacterium  nucleatum, Prevotella intermedia, 
Prevotella nigrescens, Peptostreptococcus  micros 
(Associated species included,  Eubacterium 
nodatum, Campylobacter rectus, Campylobacter 
showae,  Streptococcus constellatus, 
Campylobacter gracilis) 
                      Green Capnocytophaga,  Campylobacter concisus, 
Eikenella  corrodens,  Aggregatibacter 
actinomycetemcomitans (serotype a) 
                      Yellow Streptococcus sanguis,  Streptococcus oralis, 
Streptococcus mitis,  Streptococcus gordonii, 
Streptococcus intermedius 
                       Purple    Veillonella  parvula,  Actinomyces odontolyticus, 
Aggregatibacter  actinomycetemcomitans 
(serotype b),  Selenomonas noxia,  Actinomyces 
naeslundii genospecies 2 (Actinomyces vicosus) 
 
1:6 RED COMPLEX PREVALENCE 
Periodontal disease is a poly-microbial infection. Most forms of periodontal inflammation 
appear to be associated with elevated proportions of spirochetes of the genus Treponema 
within the subgingival plaque samples.  In the progression of periodontal disease, the “red 
complex” is considered as the most significant of the bacterial clusters since they increase in 
numbers and prevalence with increasing clinical parameters of the disease (Gmur et al, 1989, 
Haffajee, 1994; Socransky et al, 1998; Hosaka, 1994; Simonson, 1992, Holt and Ebersole, 
2005), such as in sites with deeper pockets (Kigure et al, 1995) and in areas that show 
bleeding on probing (Kasuga, 2000). The “red complex” microorganisms invade the 
periodontal pocket and are attacked by the host’s white blood cells. The ability of Tannerella 
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forsythia to induce apoptosis eliminates the host’s immune or pre-immune cells resulting in 
bacterial colonization in the periodontal pocket (Holt and Ebersole, 2005). Moreover, they 
are significantly associated with attachment loss and alveolar bone loss eventually resulting 
in tooth loss (Machtei et al, 1999). Elimination of these pathogenic bacteria by the traditional 
debridement procedures such as scaling and root planing, have been associated with an 
improved clinical response (Haffajee et al, 1997; Christersson, 1991). The synergestic 
mechanisms between species of the “red complex” contribute to immune-inflammatory 
responses (Kesavalu et al, 2007) and their interaction with the epithelial cells in the 
subgingival environment leads to the destruction of host tissues.  
Porphyromonas gingivalis interacts with Actinomyces naeslundii, which is an early colonizer 
of oral biofilms via coaggregation properties. Tannerella forsythia acts as a precursor for the 
growth and colonisation of Porphyromonas gingivalis and Treponema denticola (Dashper et 
al, 2011), and along with Porphyromonas gingivalis, coaggregates with Fusobacterium 
nucleatum enhancing colonization of subgingival plaque (Kapatral et al, 2002). 
Porphyromonas gingivalis also coaggregates with Prevotella intermedia to form a more 
mature periodontal biofilm (Kamaguchi et al, 2001). A study by Kesavalu et al (1998) 
demonstrated that in mice, an infection with Porphyromonas gingivalis and Treponema 
denticola together was more pathogenic than infection with either of the microorganisms 
alone. Individuals with high proportions of Porphyromonas gingivalis were previously 
reported to have few or absence of Prevotella intermedia and vice versa (Africa, unpublished 
data; Loesche et al, 1988). However, a mutual tolerance now appears to exist between them 
either due to their interactions with other emerging species or due to their clonal diversity 
(Africa, 2012).  
1:7 MICROBIOLOGICAL DETECTION METHODS FOR PERIODONTAL    
PATHOGENS 
The presence of periodontal pathogens has been identified by various detection techniques 
such as microscopy, culture, immunoassays, enzyme tests and DNA based techniques (Dzink, 
1988; Grossi, 1995). However, for various reasons they have been replaced by more rapid 
and sensitive tests. 
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Darkfield and phase contrast microscopy 
Increased motility of the bacterial plaque indicates a highly inflamed periodontium. 
Microscopic monitoring of bacterial morphotypes, particularly spirochaetes, in freshly 
sampled plaque is a definite diagnostic aid but the technique requires special equipment and 
is time consuming. Since most of the putative pathogens such as Porphyromonas gingivalis, 
Tannerella forsythia and Aggregatibacter actinomycetemcomitans are non-motile, this 
technique fails to identify these species and gives an end result only for a small portion of the 
ecological system (Conrads, 2001). Fluorescence microscopy has been used to detect specific 
antibodies to plaque bacteria but with higher possibilities of obtaining false negative and 
positive results (Gmur, 1988). Although an accurate assessment of disease, the inability to 
identify species is a limitation for darkfield microscopy.  
 
Culture techniques 
Culture methods are still considered as a golden standard for routine diagnostic procedure in 
medical microbiology (van Steenbergen, 1996) yet many of the periodontal pathogens are 
anaerobic and are still uncultivable (Wardle, 1997). However, the limitations of the method 
are that the procedure is time consuming and the bacteria are killed by the oxygen very 
rapidly, thus requiring rapid transportation to the laboratory. 
 
Enzyme Linked Immunosorbent Assay (ELISA) 
ELISA is an immunological method designed to detect periodontal pathogens in dental 
plaque, by using serum antibodies to detect antigens on target bacteria (Di Murro, 1997). But 
sensitivity of these tests is relatively low, requiring 10
4
 to 10
5
 bacteria per sample and the 
disease activity remains unclear due to elevated antibody titres developed by past infection. 
 
DNA based techniques 
DNA based microbiologic tests are able to extract bacterial DNA from the plaque sample 
obtained and amplify the specific DNA sequence of the target periodontal pathogens. DNA 
probes can detect non-viable species by colorimetric or chemiluminescence techniques 
(Keller, 1991). The requirement of quantitative assessment of the target bacteria resulted in 
the development of quantitative Polymerase Chain Reaction (PCR) methods. The technique 
provides large quantities of DNA in a simplified and automated manner (Dawson, 1996). 
Both the techniques can detect uncultivable species but requires sophisticated technology and 
are expensive. 
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Enzyme assay 
According to Walter Loesche and his co-workers at Michigan University, a rapid and simple 
chair side bacteriological test could be reliably used in everyday practice to identify the 
presence or prevalence of periodontal microorganisms (Loesche et al, 1992). The presence of 
Treponema denticola, Tannerella forsythia and Porphyromonas gingivalis can be determined 
or detected by an enzymatic test known as BANA (N-benzoyl-DL-arginine-naphthylamide). 
These “red complex” pathogens are cultivable plaque species which possess an enzyme 
capable of hydrolyzing the synthetic peptide of the BANA reagent (Loesche, et al, 1990). A 
positive BANA assay may indicate a high level of “red complex” members in the plaque 
sample as well as Capnocytophaga species (Loesche et al, 1987). 
 
In clinical periodontal practice, the BANA test has proved to be efficient in the diagnosis of 
periodontal disease and also in the bacteriologic monitoring of periodontally involved 
patients during the different phases of periodontal treatment (Grisi, 1998). BANA has shown 
to correlate well with the depth of the periodontal pocket and clinical indices which are used 
to diagnose periodontal disease (Grisi et al, 2001). A positive BANA result shows the 
incidence of 10,000 colony forming units of bacterial species in each plaque sample. The test 
is a reliable indicator to be used in large epidemiologic studies concerning the severity of 
periodontal infections (Puscasu, 2006). Above all, the test provides equal accuracy in 
detecting these “red complex” species comparable to that obtained with DNA probes and 
immunology. However, Andrade et al (2010) reported a sensitivity of 90% and an accuracy 
of 83% for the BANA test, taking DNA probes as the primary reference.  These authors 
concur that the BANA test is more effective in the initial diagnosis of chronic periodontitis, 
when the “red complex” pathogen levels are high.  
 
The limitation of the BANA test is that it does not identify which of the three BANA positive 
species is present in the plaque, though it may not be necessary since these species are all 
anaerobes and coexist in the same plaques. Moreover other species such as Capnocytophaga 
can also give false positive results. However, BANA helps the clinician to detect the presence 
of an anaerobic infection (Haffajee, 1998).  
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1:8 THE AETIOLOGY AND EPIDEMIOLOGY OF HUMAN 
IMMUNODEFICIENCY VIRUS (HIV) INFECTION  
 
HIV-AIDS is caused by a retroviral pathogen, the human immunodeficiency virus (HIV) 
which was identified in 1984 (Relman, 1988), and has evolved from a mysterious illness to a 
major global pandemic. AIDS was, and still is, one of the pathologies of greatest interest 
which has become a social problem for the well-being of the individual. Since its discovery in 
1981, AIDS killed more than 25 million people worldwide (Mataftsi et al, 2010). The number 
of people living with HIV still continues to grow, as new infections occur each year. WHO 
has estimated about 38 million individuals infected with one of the 10 known subtypes of 
HIV (Margiotta, 1999). South Africa has the largest HIV-positive population in the world 
followed by Nigeria and India (McNeil DG Jr, 2008). AIDS affects individuals of all age 
groups, with 98% prevalence for adults and among them 19% are women (CDC, 2003 a). 
 
HIV is a RNA virus with a particular affinity for the CD4 receptor found on the T-helper 
lymphocytes, the cells that get depleted in HIV infection. CD4 cells coordinate the immune 
response, signalling other cells in the immune system to perform their special functions. Thus 
progressive HIV infection results in loss of immune response, especially those coordinated by 
CD4+ T cells (Alves, 2006). Depletion of CD4+T lymphocytes renders the host vulnerable to 
opportunistic infections of the mouth (Coffin et al, 1997).  
 
The CD4+T lymphocyte cell count is widely used for the following purposes: 
1. To stage HIV disease 
2. For differential diagnosis of present complaints/symptoms 
3. To determine prophylaxis for opportunistic infections 
4. To decide on the initiation of antiretroviral therapy    (Doshi et al, 2008) 
 
HIV-infected patients can be grouped depending on the number of CD4+T-cells/mm
3
 (< 200, 
200-500, >500) and total lymphocytes (>2000, 1000-2000, <1000) (WHO, 1990 b). 
 
According to the 1993 Revised Classification System for HIV infection developed by Centers 
for Disease Control and Prevention, the three CD4+T lymphocyte categories are defined as 
follows: 
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 Category 1: ≥ 500  CD4+T lymphocyte cells/mm3 
 Category 2: 200-499 CD4+T lymphocyte cells/mm3 
 Category 3: < 200 CD4+T lymphocyte cells/mm3        
       
The most significant prediction from the classification was that, in HIV-infected individuals, 
a CD4+T lymphocyte count ≤200cells/mm3 or CD4+T lymphocyte percentage less 
than 14% is considered as an AIDS-defining condition. As the CD4+T lymphocyte count 
decreases, the risk of opportunistic illnesses increases. The first appearance of systemic and 
oral opportunistic infection indicates the initial immunosuppression by CD4 levels below 
500cells/mm
3
 (Lewis, 2003).  Lack of oral hygiene and reduction in CD4+T lymphocyte cell 
count less than 400 makes the host unable to control infection by the periodontal pathogens 
resulting in periodontal inflammation (Murray, 1994a). This indicates that the gradual 
depletion of CD4+T lymphocyte cells and subsequent deterioration of the immune system 
would compromise the host defence in the dento-gingival region too (Lifson, 1989). Altered 
antibody production may activate complement, stimulating periodontal inflammation (Tolo, 
1991). 
 
1:9 ROUTES OF HIV TRANSMISSION 
 
Epidemiologic research has shown that, human immunodeficiency virus infection has been 
transmitted mainly by three routes, namely, sexual contact, parenteral transmission and 
perinatal transmission (Von Reyn, 1987; Morison, 2001) 
1. Sexual contact - Although previously considered to be a disease associated with 
homosexuals only, the incidence in heterosexual transmission is rapidly increasing 
(Hansson et al, 2008).   In sub-Saharan Africa, young women are the most frequently 
affected and the main mode of transmission of HIV is heterosexual contact (UNAIDS 
2010; Subbiah et al, 2010; Schmidt et al, 2004).  
2. Parenteral transmission -  This mode of transmission occurs in three groups of high 
risk populations: 
a) Intravenous drug abusers who share unsterilized needles/syringes and other skin 
penetrating instruments (Godinho et al, 2005; Rhodes et al, 1999). 
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b) Haemophiliacs who have received large amounts of factor VIII concentrates from 
pooled blood components from multiple donors (Lifson, 1986; Simmonds et al, 
2007). 
c) Recipients of blood and blood products who have received multiple transfusions of 
whole blood or components like platelets and plasma (Vaz et al, 2010).  
3. Perinatal transmission- HIV infection is transmitted transplacentally from the infected 
mother to the foetus during pregnancy or in the immediate post-partum period through 
contamination with infected maternal blood, amniotic fluid or breast milk (McGowan 
and Shah, 2000). The overall risk of HIV transmission from an infected mother to an 
infant ranges from 25%-50% (Mok, 1987). 
 
HIV has been isolated from a number of body fluids and tissues such as: semen, vaginal 
secretions, cervical secretions, breast milk, CSF, synovial, pleural, peritoneal, pericardial and 
amniotic fluid (Friedland, 1987; Campo et al, 2006; Grivel et al, 2010). Very rarely, the oral 
cavity has been reported as a site of HIV transmission (Cohen et al, 2000; Jotwani et al, 
2004; Cutler and Jotwani, 2006). There are certain factors such as traumas in the mouth, 
ulcers or erosions of oral and/or genital mucosa, gingivitis or periodontitis, sexually 
transmitted infections, viral RNA and other oral infections (Herpes Simplex virus, 
lactobacillus, etc) which make the oral cavity a route for HIV transmission thus increasing 
the risk of HIV acquisition by oral-genital contacts (Scully and Porter, 2000).  
 
1:10 PATHOGENESIS OF HIV INFECTION 
 
The pathogenesis of HIV infection involves a certain sequence of events and is shown in 
Fig.1 (Mohan, 2005). HIV infection is manifested by both continual virus replication and a 
vigorous immune response (Andrews, 1996). The pathogenesis of HIV infection is 
extensively related to depletion or reduction of CD4+T helper cells causing profound 
immunosuppression. However, monocytes, macrophages, Langerhans cells and some 
neuronal and glial brain cells are also attacked by the human immunodeficiency virus without 
any cytopathic effect on these cells. Replication of the virus takes place often in the 
lymphoreticular tissues of lymph nodes, spleen, gut-associated lymphoid cells and 
macrophages (Fauci, 1993). Several factors such as viral, host and environmental factors 
influence the progression of HIV to AIDS within 10 years of HIV infection. However, the 
rate of progression differs with individuals (Buchbinder, 1994). .                               
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                                        Interaction of gp 120 of HIV to CD4+T cell 
  
 
                                                  Internalisation of virion                                                    
 
 
                                                      Uncoating of virion 
 
                              Reverse transcriptase 
 
Other virus infection                         Proviral DNA                                         CD4+Tcell lysis    
                                                      Unintegrated, integrated 
 
  
  
                     Activated CD4+T cell                            Inactive CD4+T cell 
 
                                                                                         Latent phase               
                    Budding of virus particle 
                    Syncytia formation 
 
                          Cytopathic phase    
 
 
  
Quantitative                                                                    Qualitative         
depletion of CD4+T cells                                         failure of CD4+T cells 
                                                                                   to respond to antigens 
                                                                                                       
Fig.1 Diagrammatic representation of sequence of events in the pathogenesis of HIV 
infection (Mohan, 2005) 
 
 
 
 
 
25 
 
1:11 PERIODONTAL DISEASES AND HIV INFECTION 
 
In 1987, Winkler and Murray reported the presence of a distinctive form of periodontal 
disease in HIV seropositive individuals. Since then, HIV-associated periodontal disease has 
been considered as one of the earliest clinical features of HIV infection (Robinson, 2002). 
The periodontal diseases frequently associated with HIV infection are the following:   
(Armitage 1999; Coogan 2005) 
 Linear gingival erythema (LGE) 
 Necrotizing ulcerative gingivitis (NUG) and Necrotizing ulcerative periodontitis 
(NUP) 
 Acute necrotising stomatitis (ANS) or Necrotising ulcerative stomatitis (NUS) 
 Chronic periodontitis with an increased rate of attachment loss   
 
The primary difference between these oral diseases is their clinical severity. LGE or “red 
band” gingivitis is characterized by a distinct red band along the gingival margin, usually 
associated with anterior teeth but commonly extending to the posterior teeth. It may or may 
not be accompanied by bleeding or discomfort. Occasionally it appears as petechia-like 
patches on attached or free gingiva (Reznik, 2006). NUG is characterized by an acute painful 
inflammation of the gingiva with rapid destruction of soft tissues, while NUP is involved by a 
bleeding and sharp pain with extensive soft tissue necrosis and advanced loss of periodontal 
attachment, possibly exposing bone (Greenspan and Greenspan, 2008). NUG and NUP, if 
untreated, can progress to ANS which is manifested by the extension of necrosis past the 
periodontium into the mucosa and the osseous tissue (Robinson et al, 1998 a).  
 
Factors which may predispose an individual to aggressive gingivitis or periodontitis 
unresponsive to conventional therapy (Winkler, 1992; Schenkein, 1994) may include sex, 
race, age, smoking, poor oral hygiene, malnutrition, stress, and socioeconomic status of 
individuals, some systemic diseases such as diabetes , impaired neutrophil function and state 
of immunosuppression (AIDS, leukaemia) (Fleming, 1999; Umeda, 1998; Tucker, 2006).  
Studies report that NUG and NUP are significantly associated with severe 
immunosuppression indicated by a CD4+T cell counts less than 200 cells/mm
3
 (Margiotta et 
al, 1999; Kroidl et al, 2005). It is considered that the severe immunosuppression in HIV 
patients may exacerbate pre-existing periodontitis (Kinane, 1999 b). The course of the disease 
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is further associated with increasingly severe gingival inflammation, progressive destruction 
of ligament fibers and alveolar bone loss (Hilton, 1995; Salvi, 1997).  
HAART or highly active antiretroviral therapy is defined as a treatment regimen that 
included at least three different antiretroviral drugs from at least two different classes, i.e, 
nucleoside/nucleotide analogues (NUC), protease inhibitors (PI), non-nucleotide reverse 
transcriptase inhibitors (NNRTI) and entry or fusion inhibitors (EI) (Vernon et al, 2009). A 
study conducted after the introduction of HAART, suggested that these diseases were not 
related to HIV serostatus or CD4+T cell counts (Schuman et al, 1998). According to a study 
by Patton (2000 a), LGE has a predictive value of 70% for immunosuppression, whereas, in 
another study by Glick et al (1994), NUP showed a positive predictive value of 95.1% which 
makes NUP a good marker for immune deterioration. A recent study conducted in South 
Africa, demonstrated a significant correlation between necrotizing diseases and severe 
immnunosuppression, with a positive predictive value of 69.6% (Shangase et al, 2004). 
Moreover, a study conducted by Bolscher et al (2002), reported that the presence of oral 
lesions and periodontal disease results in a continuous shedding of HIV infected blood from 
mucosal and gingival lesions into the oral cavity, with an increased possibility for the 
transmission of HIV.  
Researchers have suggested a higher prevalence and severity of periodontal diseases in HIV 
infected individuals ranging from 1-66% for gingivitis and 0-91% for periodontitis 
(Ranganathan et al, 2000; Eyeson et al, 2000). However, controversy exists, as investigations 
demonstrated that the prevalence of the disease in HIV infected patients is highly variable 
(Laskaris, 1992; McKaig, 1998 b) with some studies reporting differences in  clinical indices 
between  HIV-positive  and HIV-negative subjects,  while others report no differences in 
clinical indices regardless of CD4+T cell counts and viral loads (Alves, 2006).  The reason 
for the conflicting reports may be due to the different populations studied, lack of consensus 
criteria for disease, patient’s state of immunosuppression, antiretroviral therapy, study 
location and biased samples (Murray, 1994 b). The implication of HIV as a risk factor for 
susceptibility to periodontal disease is based  on evidence from cross-sectional surveys and 
not longitudinal studies (Papapanou, 1998 b).  A cross-sectional study conducted by McKaig 
et al (1998 b) included 326 HIV-infected individuals in whom the presence of adult 
periodontitis was demonstrated by measurement of probing depth and clinical attachment loss 
of ≥5mm in  62% and 66% respectively. In their study, only a few HIV-positive patients 
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(n=15) showed the presence of HIV-associated periodontitis. As mentioned earlier, 
periodontal disease is initiated by the overgrowth of certain Gram-negative, anaerobic 
bacteria growing in the subgingival sites during infection (Xiong, 2006). According to recent 
research, these bacteria or their toxins can be released into the blood stream, thus activating 
the immune system (Fowler, 2001; John, 2002). Several studies have reported HIV infection 
as a risk factor for the progression of chronic periodontitis, while others suggest that the 
presence of oral opportunistic pathogens and periodontal diseases in HIV-positive patients 
may influence HIV reactivation and progression (Mataftsi et al, 2010; Imai et al 2012)  
Whether necrotising periodontal disease is exacerbated by HIV infection or whether the 
progression and reactivation of HIV infection occurs as a result of periodontal disease 
remains unclear (Robinson, 2002; Bascones-Martinez and Escribano-Bermejo, 2005).     
Defects in the systemic host immune response are known to play a characteristic role in 
aggressive periodontitis (Schenkein, 1994), with the severity of probing pocket depth, 
attachment loss and gingival recession reported to correlate well with the degree of 
immunosuppression (McKaig, et al, 2000 a, Pedreira et al, 2008). Studies of chronic 
periodontitis (Barr et al, 1992; Yeung et al, 1993; Lucht et al, 1991; Reichart et al, 2003). 
and necrotising periodontitis (Clearinghouse;  Shibosky et al, 2009)  reported a higher risk of 
attachment loss in HIV-positive patients with chronic periodontitis, exhibiting  CD4+T 
lymphocyte counts of <200cells/mm
3
. An increase in the proportions of Th2 type 
lymphocytes in HIV-infected patients was reported when comparing chronic gingivitis with 
NSG (necrotising SG) (Gomez et al, 1997).   
 
In a workshop conducted by Robinson et al (2002), a need for further research was   
recommended to determine the effectiveness of interventions for the management of 
necrotizing periodontal disease and HIV-associated morbidity and mortality (Slots 2003 c). 
Earlier intervention with antiretroviral therapies and the widespread use of HAART in 1995, 
could limit the exposure to immunosuppression (CD4+T cell count less than 200cells/ mm
3
), 
hence reducing the incidence of many AIDS-related opportunistic infections (Paul et al, 
2002). The advantage in the use of HAART is that it increases the CD4+T cell counts and 
decreases the level of HIV RNA, thus reducing the morbidity in HIV disease for a short-term 
(Palella et al, 1998). Even though the introduction of HAART highly reduces the frequency 
and severity of oral diseases, the majority of HIV-infected individuals with limited access to 
anti-HIV therapy continue to develop oral disease (Frezzini et al, 2005). The literature reports 
a reduction of about 47-85% in the overall prevalence of oral lesions prior to the introduction 
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of HAART, with a gradual decline of 32-46% following the introduction of HAART (Gaitan 
Cepeda et al, 2008), thereby demonstrating a lack of substantiating evidence of the effect of 
HAART on the progression of periodontal disease (Schmidt-Westerhausen et al, 2000). 
Feller et al (2006), during his study on oral diseases among HIV-infected individuals, 
reported that standard periodontal therapy and adequate oral hygiene maintanence may 
improve the clinical condition of HIV or AIDS patients. A retrospective cross-sectional study 
conducted by Engeland et al (2008) established that tooth loss due to periodontal disease in 
HIV-infected individuals was not influenced by their CD4+T cell counts or their viral loads. 
They observed no significant differences among the HIV-positive patients before dental 
treatment, after initial periodontal treatment and following a 2-year maintenance period even 
during antiretroviral therapy.  
 
Drug interactions occur between the drugs used in periodontal therapy and antiretroviral 
medications and it is therefore important for the dentist to have a proper understanding of the 
drugs used for the treatment of periodontal disease in HIV-positive patients (Goncalves et al, 
2010). The progression of chronic periodontitis may lead to severe invasion of opportunistic 
infections and destructive inflammatory response in HIV-positive patients highlighting the 
need for the introduction of newer systemic therapies to improve the immunocompetence of 
the patients (Ryder, 2002).   
Oral lesions in HIV infection should therefore always be considered significant (Chapple and 
Hamburger, 2000) since they may:  
1. indicate HIV infection in previously undiagnosed cases 
2. predict the severity of HIV disease 
3. represent early clinical features of clinical AIDS (for example, oral Kaposi sarcoma) 
4. act as a traditional entry or exit determinant for antiretroviral therapy 
5. determine anti-opportunistic infection therapy 
6. be used in disease staging and classification 
7. individually correlate with CD4 levels in severely immunosuppressed patients 
8. correlate with CD4 levels when grouped together (for CD4 counts <200 ×106/µl) 
9. act as cofactors affecting the rate of HIV 
Careful oral screening among the HIV-infected individuals is necessary for an early diagnosis 
and treatment of periodontal disease and other oral manifestations (Gennaro et al, 2008), and 
the combined effort of the physician and the dentist are necessary to diagnose and manage 
these conditions effectively (Weinert, et al, 1996). 
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1:12 SUBGINGIVAL MICROBIAL COMPLEXES IN HIV-POSITIVE PATIENTS 
HIV-associated periodontitis can be regarded as an important diagnostic and prognostic 
marker (Coogan et al, 2005), since oral manifestations are among the first clinical 
expressions of HIV infection (Piluso et al, 1993). Thus far, no specific single organism has 
been implicated for periodontal disease in HIV seropositive individuals (Murray et al, 1989) 
although several reports indicate the presence of mixed microflora not usually associated with 
oral infections, such as Escherichia coli, Clostridium, Mycoplasma and Klebsiella 
pneumoniae in HIV seropositive and seronegative individuals (Zambon et al 1990; Patel et 
al, 2003).  This may be due to the immune status of those patients, since humoral and cellular 
immunity changes can facilitate the colonization and overgrowth of atypical pathogenic 
species (Paster et al, 2002). High concentrations and diffuse invasion of these bacteria into 
the gingival tissues may lead to increased secretion of inflammatory mediators resulting in 
rapid periodontal destruction (Murray et al, 1994).  The increased prevalence of periodontitis 
and oral diseases in HIV-infected patients caused by non oral pathogens in the mouth may 
also result in HIV reactivation (Gonzalez et al, 2009). Since periodontitis is a polymicrobial 
infection, the presence of Gram-positive and Gram-negative pathogens may exhibit 
synergestic mechanisms eliciting the activation of HIV immune cells (Huang et al, 2011), 
while the virulence mechanisms of the periodontopathogens are responsible for the 
occurrence of chronic inflammatory periodontal disease in HIV patients contributing to 
AIDS.  
Several studies report that microbial complexes of HIV-associated periodontal diseases are 
not significantly different from those in HIV-negative individuals with periodontal diseases 
(Brady et al, 1996; Tsang and Samaranayake, 2001; Teanpaisan et al, 2001; Alpagot et al, 
2004) although some increase in Gram-negative anaerobes (Barr, 1995; Patel et al, 2003) and 
Candida have been reported (Zambon et al, 1990). IgG subclass antibody responses to 
periodontal pathogens have also demonstrated no difference between HIV-positive and HIV-
negative patients (Yeung et al, 2002).  The “red complex” microorganisms namely the potent 
periodontopathogenic bacteria Porphyromonas gingivalis, Tannerella forsythia and 
Treponema denticola, are considered as risk factors in HIV patients (Goncalves et al, 2004 
b). Cross and smith (1995) compared plaque from HIV-positive and HIV-negative 
periodontal patients and detected a 75-100% prevalence in HIV-positive patients for 
Aggregatibacter actinomycetemcomitans, Campylobacter rectus, Veillonella parvula, 
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Capnocytophaga ochracea, Porphyromonas gingivalis, Prevotella intermedia and Tannerella 
forsythia (Table.2). However, other studies reported a lower prevalence of these putative 
bacteria in HIV-positive compared with HIV-negative individuals (Goncalves, 2007; 2009). 
The pathogenic potential of Porphyromonas gingivalis and Tannerella forsythia in adult 
periodontitis has been reported by van Winkelhoff et al (2002), with a recent study 
demonstrating that Porphyromonas gingivalis infection could increase HIV infection 
transmission through the oral cavity (Giacaman et al, 2007). Conversely, a high prevalence of 
Tannerella forsythia (81.8%) was in individuals with a low prevalence and severity of adult 
periodontitis (Tran et al, 2001). Consequently, the microbial associations of HIV associated 
periodontal diseases are not thoroughly understood (Aas et al, 2007).  
The immunosuppression in HIV-infected individuals triggers the re-activation of human 
herpes virus (HHV) infection leading to severe chronic periodontitis and HIV-associated 
periodontal disease. (Slots and Contreras, 2000; Cappuyns, 2005) with several herpes viruses, 
especially Cytomegalovirus (HHV 5), Epstein-Barr virus type-I (HHV4) (Contreras et al, 
1999) and HHV-6, HHV-7 and HHV-8 detected with higher frequency in subgingival plaque 
samples from HIV-positive individuals with periodontal disease than from healthy or HIV-
negative subjects (Mardrossian et al, 2000).   
Table.2 presents bacteria and viruses associated with periodontal disease in HIV-positive 
individuals and Table.3 presents some of the oral bacteria found in HIV-positive individuals 
but not associated with periodontal disease.  
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Table.2 Bacteria and viruses associated with periodontal diseases in HIV-positive 
individuals  
           BACTERIAL SPECIES                      REFERENCES 
Aggregatibacter actinomycetemcomitans 
Fusobacterium nucleatum 
Porphyromonas gingivalis 
Prevotella intermedia 
Tannerella forsythia 
Treponema denticola 
Veillonella parvula 
Capnocytophaga ochracea 
Murray et al, 1989 
Cross and Smith, 1995 
Scully et al, 1999 
Alpagot et al, 2004 
Candia albicans and other Candida species Jabra-Rizk et al, 2001 
Eikenella corrodens 
Campylobacter rectus 
Murray et al, 1991 
Rams et al, 1991 
Moore et al, 1993 
Cytomegalovirus (HHV 5) 
Epstein-Barr virus type-I (HHV4) 
Contreras et al, 1999 
HHV-6  
HHV-7   
HHV-8 
Mardrossian et al, 2000 
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Table.3 Oral bacteria found in HIV-positive individuals, but not associated with 
periodontal disease 
       BACTERIAL SPECIES                 REFERENCES 
Enterobacter faecalis Zambon et al, 1990 
Nakou et al, 1997 
Goncalves et al, 2004; 2007 
Clostridium clostridiiforme Zambon et al, 1990 
Clostridium difficile Zambon et al, 1990 
Nakou et al, 1997 
Goncalves et al, 2007 
Klebsiella pneumonia 
Escherichia coli 
Zambon et al, 1990 
Nakou et al, 1997 
Botero et al, 2007 a 
Goncalves et al, 2007 
Mycoplasma salivarium Zambon et al, 1990 
Moore et al, 1993 
Nakou et al, 1997 
Goncalves et al, 2007 
Pseudomonas aeruginosa Nakou et al, 1997 
Botero et al, 2007 a 
Goncalves et al, 2007 
Acinetobacter baumanii Nakou et al, 1997 
Goncalves et al, 2007 
Enterobacter cloacae Nakou et al, 1997 
Botero et al, 2007 a 
Entamoeba gingivalis 
Enterococcus faecalis  
Enterococcus avium 
Chattin et al, 1999 
Lucht et al, 1998 
Campylobacter pylori Aas et al, 2007 
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2: SUMMARY 
Although the oral cavity may be a primary source of infection in any individual, it is a 
frequently undervalued, yet significant source of diagnostic and prognostic information in 
patients with HIV disease. HIV infection results in impaired immune response mediated by 
CD4+T cell lymphocyte counts contributing to severe periodontal manifestations. Many 
studies referred to above, show the association between periodontal clinical indices and 
immunosuppression in HIV-infected individuals supporting HIV infection as a risk factor for 
chronic periodontitis.  However, several studies failed to associate any relationship between 
the immunosuppression of the patients and periodontal disease. Strong evidence suggests that 
periodontal disease is a polymicrobial infection, associated with potential 
periodontopathogens including Porphyromonas gingivalis, Tannerella forsythia and 
Treponema denticola, commonly referred to as the “red complex”. 
The above literature highlights the need to determine whether any association exists between 
the immunosuppression in HIV-infected individuals and periodontal disease. This study will 
focus on the presence of “red complex” pathogens using the BANA test and will investigate 
and compare the degree of immunosupppression of the patients with the presence and 
severity of periodontal disease by measurement of their clinical indices.   
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3: AIMS AND OBJECTIVES 
3:1 AIMS 
To determine the association of periodontal diseases and the presence of “red complex” 
pathogens in HIV-positive patients with different CD4+T lymphocyte levels. 
3:2 OBJECTIVES 
1. To determine an association between clinical indices used in the diagnosis of 
periodontal disease across different CD4+T lymphocyte levels. 
2. To seek an association between CD4+T lymphocyte counts and the presence of 
Porphyromonas gingivalis, Tannerella forsythia and Treponema denticola (“red 
complex”) using the BANA test. 
3. To associate the clinical indices of periodontal disease with the BANA test  
 
3:3 NULL HYPOTHESIS 
No significant association exists between CD4+T lymphocyte levels and “red complex” 
pathogens of chronic inflammatory periodontal disease in HIV-positive patients. 
4: MATERIALS AND METHODS 
4:1 STUDY DESIGN  
A cohort descriptive study of HIV-positive patients was conducted.  
4:2 ETHICAL CONSIDERATIONS 
Informed consent was obtained from the participants in verbal and written form as defined by 
the “World Medical Association Declaration of Helsinki, Ethical Principles for Medical 
Research Involving Human Subjects” of 2008 (Appendix 4:2 A).  
 
Ethical clearance was obtained from the UWC research ethics committee (Appendix 4:2 B) 
and a translator was available in the clinic to ensure that the patients fully understood the 
nature of the study and the benefits and potential risks of the study. Their right to refuse 
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participation at any time was accepted (Appendix 4:2 C). A questionnaire was completed by 
them containing items designed to obtain information regarding medical history, factors 
predisposing for periodontal disease, and oral hygiene habits (Appendix 4:2 D). Patients 
requiring treatment for periodontal disease were referred to the Tygerberg Oral Health Centre 
(UWC) and were treated by well experienced dental professionals.  
4:3 SAMPLE SIZE 
The study sample included 120 HIV-positive patients attending the infectious disease clinic at 
Tygerberg Medical Hospital, Western Cape. A randomized selection of the patients was 
conducted. No oral hygiene instructions were given prior to the sample collection. 
4:4 INCLUSION CRITERIA 
- All the HIV-positive patients with various CD4+T lymphocyte counts 
- Patients with or without ART 
 
4:5 EXCLUSION CRITERIA 
- Patients on antibiotic treatment 
- Patients with cardiovascular disease, diabetes, TB, autoimmune diseases 
- Pregnancy  
- Patients who have undergone dental treatment in the past 3 months (since chances of 
finding infections will be less in those patients) 
 
4:6 MATERIALS 
4:6:1 For clinical examination: 
- Sterile mouth mirrors 
- Sterile Williams periodontal probe 
- Chlorhexidine solution 
 4:6:2 For BANA test: 
- Sterile cotton-tipped swabs 
- Sterile cotton rolls 
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- Sterile scaling curette (Gracey curette 11/12, 13/14) 
- BANA test strips 
- BANA incubator 
- Distilled water 
- Cotton balls or wetting applicator bottle 
- Sterile clear, non-porous tape 
- Biohazard waste bags 
4:6:3 Technical specifications of BANA incubator: 
- Voltage:              120 VAC, 60 Hz 
-  Amperage:          170 mA 
-  Watts:                 20 W 
4:7 METHODS 
4:7:1 Clinical assessment  
The clinical assessment included patient history, recording of clinical indices and oral lesions 
(if present). The CD4+T lymphocyte cell counts were obtained from their medical records 
(Appendix 4:7:1 E).  
Periodontal measurements were taken on the mesial aspect of the six Ramfjord teeth. The 
following teeth were selected: 
- Maxillary right first molar (16) 
- Maxillary left central incisor (21) 
- Maxillary left first bicuspid (24) 
- Mandibular left first molar (36) 
- Mandibular right central incisor (41) 
- Mandibular right first bicuspid (44) 
Missing teeth were substituted by the following teeth: 
- 16: by the mesial of 15, if not by the distal of 17 
- 21: by the distal of 22 
- 24: by the distal of 25 
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- 36: by the mesial of 35, if not by the distal of 37 
- 41: by the distal of 42 
- 44: by the distal of 45 
 
The amount of plaque present was assessed using the criteria of plaque index (PI) introduced 
by Silness and Loe (1964) and were scored from 0-3 (Table.4). 
 
Table.4 Plaque Index (Silness and Loe, 1964) 
Scores                                Criteria 
    0 No plaque in the gingival area 
    1 A film of plaque adhering to the free gingival margin and adjacent area of the 
tooth. The plaque may be recognized only by running the probe across the tooth 
surface. 
    2 Moderate accumulation of soft deposits within the gingival pocket and on the 
gingival margin and/or adjacent tooth surface that can be seen by the naked eye. 
    3 Abundance of soft matter within the gingival pocket and or on the adjacent tooth 
surface and gingival margin. 
Gingival inflammation was assessed by the gingival index (GI) introduced by Loe and 
Silness (1963) and was scored from 0-3 (Table.5). 
Table.5 Gingival Index (Loe and Silness, 1963) 
  Scores                                               Criteria 
      0 Absence of inflammation 
      1 Mild inflammation- slight change in colour and little change in texture of any 
portion of the marginal or papillary gingival unit 
      2 Moderate inflammation- glazing, redness, edema and hypertrophy of marginal 
or papillary gingival unit. Bleeding on probing 
      3 Severe inflammation, marked redness and hypertrophy of the marginal or 
papillary unit. Spontaneous bleeding, congestion or ulceration. 
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Probing pocket depth (PPD) was measured from the gingival margin to the base of the pocket 
using Williams periodontal probe with markings to the nearest millimetre. Clinical 
attachment loss (CAL) was measured from the cementoenamel junction to the base of the 
pocket using the above mentioned probe. The probing depth and/or attachment loss were 
measured based on the periodontal disease classification system recommended by the 1999 
International Workshop for classification of periodontal diseases and conditions, accepted by 
American Academy of Periodontology (AAP) (Colin, 2000). They were measured as follows; 
Slight = 1-2mm 
Moderate = 3-4mm 
Severe = ≥ 5mm 
 
4:7:2 BANA hydrolysis assay 
 
The BANA reagent strip consisted of a plastic strip to which two separate reagent matrices 
were attached; 
- The lower white reagent matrix was impregnated with N-benzoyl-DL-arginine-B-
napthylamide (BANA). 
- The upper buff reagent matrix contained a chromogenic diazo reagent, Fast Black K. 
A BANA test strip was taken from the bottle just prior to use, as the test reagents were 
sensitive to light and humidity. The patient’s name, date and site information were recorded 
in the marked space on the test card.  
 
4:7:2:1 Subgingival plaque sampling 
Subgingival plaque sample was collected from the site with the maximum pocket depth.  The 
supragingival plaque was removed from the specific tooth prior to sampling and the tooth 
was isolated using sterile cotton rolls. A gracey curette was inserted deep into the apical third 
of the pocket and subgingival plaque collected. The specimen taken was dispersed on the 
lower reagent matrix of the BANA test strip.  
 
4:7:2:2 BANA testing 
After the desired plaque sample has been transferred to the lower matrix, the upper matrix 
was moistened with distilled water on a cotton swab. Care was taken to just moisten and not 
wet the upper matrix with too much water thus diluting the blue colour, resulting in a false 
negative interpretation. The BANA test strip was folded at the perforation mark so that the 
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upper and the lower matrices meet. The BANA strip was then placed into one of the top slots 
of the incubator. The incubator cycle began when the indicator light was on and was 
incubated for 15 minutes at 55˚c. The BANA test strip was then removed from the incubator 
and the lower strip at the perforation was discarded as contaminated waste. The reason for 
this disposal was that the lower portion of the strip may contain traces of pathogenic bacteria, 
viruses and beta-napthylamine, a potentially carcinogenic end product of BANA hydrolysis. 
Care was also taken to avoid handling the lower portion of the test strip which would contain 
the original plaque sample. 
 
If BANA positive species were present when the test strip was opened, a permanent blue 
colour was obtained on the upper matrix. The higher the concentration of bacterial species, 
the darker the blue colour obtained. Results were reported as positive, weakly positive or 
negative. 
 
BANA test results were interpreted as the following: 
 Positive reaction- This appeared as a distinct blue colour in very small zones or over 
the entire contact area of the plaque sample. A positive reaction indicated the presence 
of more than 10,000 colony-forming units of the BANA anaerobes in the specimen. 
These levels may indicate the incidence of clinical periodontal disease and/or oral 
malador in those patients. 
 Weakly positive reaction- This appeared as a faint blue colour in small zones or over 
the entire contact area of the specimen. A faint intensity indicated the presence of low 
levels of BANA positive species in a plaque sample and was evaluated by the 
patient’s history of periodontal disease and current clinical status.    
For statistical analyses, both strong and weakly positive results were recorded as 
positive. 
 Negative reaction- Absence of colour indicated the absence of BANA anaerobes in 
the plaque specimen, i.e, below 10,000 colony forming units at the sample site. A 
negative BANA test showed periodontal health or no oral malador.  
 
The result thus obtained was recorded in the respective patient’s data collection chart and the 
upper coloured strip was preserved by sealing with clear, non porous tape and attached to the 
patient’s chart for future reference. 
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4:8 DATA ANALYSIS  
 
Data was analyzed using statistical programmes such as SAS (SAS Institute Inc., Cary, NC, 
USA). All questionnaires, oral examinations and laboratory data were entered into a 
computer spread sheet programme, Excel. The Wilcoxon rank sum test was used to determine 
the association between CD4+T cell counts and each of the clinical periodontal parameters 
with BANA. Bivariate relationships between continuous variables were determined by 
Spearmans rank correlation test. Pearsons chi-square test was applied to determine the 
association between “red complex” and periodontal status. A significance level of <0.01 
rather than the usual <0.05 level indicated a highly significant result, while results with a p-
value between 0.01 and 0.05 were referred to as marginally significant. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
41 
 
5: RESULTS 
5:1 Health Risk Assessment Questionnaire 
Prior to the clinical examination, all the patients were given a set of consent forms and 
questionnaires. They were asked to sign the consent forms to show their valuable 
participation in the study and also to complete the questionnaires in order to identify any 
predisposing or risk factors that might lead to periodontal disease. Table.6 shows the 
frequency distribution of the patients and their response to the questionnaires.  
Of the 120 patients examined, 54.2% were females and 45.9% were males. The majority of 
patients were blacks (59.2%) followed by coloureds (31.7%), expatriates (8.4%) and whites 
(0.9%). About 19.2% of them had no formal education followed by 44.2% and 32.5% who 
attended primary and high school respectively. Only 4.2% had university education. Around 
fifty percent lived in flats and 45.9% lived in shacks while 3.4% were homeless. 
Seventy percent reported brushing once a day and only 30% brushed twice a day. Only 
21.7% used interdental aids to clean their teeth whereas 78.4% never used interdental aids. 
About 19.2% of the individuals admitted to never visiting a dentist while 10.9% claimed to 
maintain their dental visit every year for five years. Very few of them claimed to visit the 
dentist three times (4.2%) and four times (2.5%) in five years, whereas, 51.7% and 11.7% 
maintained their dental checkups only once and twice in five years respectively. 
Among the study population, half of them were current smokers (50%) and half of them were 
(50%) were non-smokers. Most of the patients (60.9%) were on antiretroviral therapy and the 
rest (39.2%) were not on therapy. Other sexually transmitted diseases were reported by 
41.7% whereas 58.4% were free of other sexually transmitted diseases. 
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Table.6 Characteristics and frequency distribution of the study population 
Characteristics Frequency Percentage 
Gender 
Males 
Females 
 
55 
65 
 
45.9% 
54.2% 
Race 
Blacks 
Whites 
Coloureds 
Others 
 
71 
1 
38 
10 
 
59.2% 
0.9% 
31.7% 
8.4% 
Level of Education 
No formal education 
Primary school 
High school 
University 
 
23 
53 
39 
5 
 
19.2% 
44.2% 
32.6% 
4.2% 
Living Conditions 
Homeless 
Flat 
Shack 
 
4 
61 
55 
 
3.4% 
50.9% 
45.9% 
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Table.6 (continued) 
Dental History 
Dental visits in 5years 
Never 
Once 
Two times 
Three times 
Four times 
Five times 
Brushing Frequency 
Once a day 
Twice a day 
Use of Interdental aids 
Yes 
No 
 
 
23 
62 
14 
5 
3 
13 
 
84 
36 
 
26 
94 
 
 
19.2% 
51.7% 
11.7% 
4.2% 
2.6% 
10.9% 
 
70% 
30% 
 
21.7% 
78.4% 
Current Smokers 
Yes 
No 
 
60 
60 
 
50% 
50% 
Antiretroviral Therapy 
Yes 
No 
 
73 
47 
 
60.9% 
39.2% 
STD 
Positive 
Negative 
 
50 
70 
 
41.7% 
58.4% 
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5:2 Oral hygiene and clinical indices 
 
5:2:1 Association between clinical indices with the frequency of brushing 
Among the clinical indices only plaque index (p= 0.0352) showed a significant association 
with the brushing habit of the patients. The median for the clinical indices were higher for 
those who brushed once a day compared to those who brushed twice a day. Table.7 shows 
significant association found between frequency of brushing and plaque index using 
Wilcoxon rank sum test. None of the other clinical indices showed any significant 
associations with brushing. 
5:2:2 Associations between clinical indices with the use of interdental aids 
 
Plaque index (p= 0.0110), gingival index (p= 0.0102) and clinical attachment level (p= 
0.0336) showed significant associations with interdental aids except for the probing depth 
Table.8 shows significant results between the use of interdental aids with plaque index, 
gingival index and clinical attachment level using Wilcoxon rank sum test. 
 
Table.7 Clinical indices relative to frequency of brushing 
            Frequency of Brushing 
               Once a day (N=84)         Twice a day (N= 36)  
Variables Mean(SD) Median Minimum-
Maximum 
Mean(SD) Median Minimum-
Maximum 
P value 
Plaque 
index 
2.63(0.4) 2.9 1.2-3 2.38(0.58) 2.4 0.8-3 0.0352 
Gingival 
index 
2.79(0.4) 3 1.4-3 2.67(0.53) 2.9 0.5-3 0.0911 
Probing 
depth 
4.86(1) 5 2.9-6.8 4.55(1) 4.15 3-6.8 0.1376 
Clinical 
attachment 
level 
5.39(1.1) 5.6 3-7.3 5.06(1) 5 3.3-7 0.1101 
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Table.8 Clinical indices relative to interdental aids 
                                                            Use of Interdental aids  
                     Yes (N= 26)                            No (N= 94)  
Variables Mean(SD) Median Minimum-
Maximum 
Mean(SD) Median Minimum-
Maximum 
p value 
 
Plaque 
index 
2.27(0.6) 2.2 0.8-3 2.63(0.49) 2.9 1.2-3 0.0110 
Gingival 
index 
2.57(0.59) 2.85 0.5-3 2.8(0.39) 3 1.4-3 0.0102 
Probing 
depth 
4.45(1.17) 4 3-6.5 4.86(0.99) 5 2.9-6.8 0.0762 
Clinical 
attachment 
level 
4.89(1.12) 4.6 3.3-6.9 5.3(1.07) 5.6 3-7.3 0.0336 
  
 
 
5:3 Descriptive statistics of age, CD4+T cell counts and periodontal indices 
The mean age of the study population was 33.3years with a median of 32years (Table.9). The 
mean plaque index score (2.55) was the lowest among the periodontal indices with the 
highest being the mean clinical attachment level (5.29mm). The mean probing depth was 
4.77mm and the mean gingival index score was 2.75 with a median score of 4.9mm for 
probing depth and 3 for gingival index.  
The actual CD4+T lymphocyte mean level was 293.5cells/mm
3
. The HIV infected patients 
were grouped depending on their CD4+T cell counts into those with <200 cells/mm
3
,       
200-500cells/mm
3
 and >500cells/mm
3
. Fig.2 shows CD4+T cell counts grouped by intervals 
of 100 rather than the coarser grouping of <200, 200-500 and >500cells/mm
3
. Thirty percent 
had a CD4+T cell count <200cells/mm
3 
indicating severe immunosuppression with a lower 
mean 135.67cells/mm
3
 compared to 59.2% individuals with CD4+T cell counts of 200-
500cells/mm
3
 with a mean of 321.27cells/mm
3
. Only 10.9% of the patients had a CD4+T cell 
count >500cells/mm
3
 with the highest mean (578.24cells/mm
3
) compared to other groups.  
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Table.9 Mean (SD) and Median of age, CD4+T cell counts and periodontal indices 
Variables   N Mean (SD) Median Minimum-Maximum 
Age (years) 120 33.3(7.42) 32 20-55 
CD4+T cell counts 120 293.5(151.06) 294.5 36-859 
Plaque index 120 2.55(0.54) 2.8 0.8-3 
Gingival index 120 2.75(0.45) 3 0.5-3 
Probing depth 120 4.77(1.04) 4.9 2.9-6.8 
Clinical attachment 
level 
120 5.29(1.1) 5.35 3-7.3 
CD4+T cell groups 
<200 cells/mm
3 
200-500 cells/mm
3 
>500 cells/mm
3 
 
36 (30%) 
71(59.2%) 
13(10.9%) 
 
135.67(37.5) 
321.27(87.9) 
578.24(100.0) 
 
136 
312 
534 
 
36-190 
200-500 
510-859 
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Fig.2 Frequency distribution of CD4+T cell counts grouped into intervals of 100 and 
plotted against the midpoint 
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Table.10 Descriptive statistics for grouped CD4+T cell counts relative to clinical indices 
Group N Variables N Mean(SD) Median Minimum-
Maximum 
<200cells/mm
3
 36 Plaque 
index 
36 2.59(0.49) 2.9 1.3-3 
  Gingival 
index 
36 2.8(0.36) 3 1.9-3 
  Probing 
depth 
36 4.6(0.95) 4.16 2.9-6.4 
  Clinical 
attachment 
level 
36 5.09(1.06) 5 3-6.9 
200-500cells/mm
3
 71 Plaque 
index 
71 2.52(0.55) 2.8 0.8-3 
  Gingival 
index 
71 2.74(0.48) 3 0.5-3 
  Probing 
depth 
71 4.83(1.07) 4.9 3-6.8 
  Clinical 
attachment 
level 
71 5.37(1.07) 5.5 3.3-7.3 
>500cells/mm
3
 13 Plaque 
index 
13 2.59(0.56) 2.8 1.2-3 
  Gingival 
index 
13 2.7(0.52) 3 1.4-3 
  Probing 
depth 
13 4.86(1.17) 5 2.9-6.5 
  Clinical 
attachment 
level 
13 5.44(1.36) 5.9 3-7 
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5:4 Grouped CD4+T cell counts and clinical indices 
The median for plaque index was higher in HIV-positive patients with CD4+T cell counts 
<200cells/mm
3
 compared to those with CD4+T cell counts >500cells/mm
3
 and those with      
200-500cells/mm
3
. Table.10 shows the descriptive statistics for grouped CD4+T lymphocyte 
levels with clinical indices. While no difference was found between gingival index in HIV- 
positive patients with CD4+T cell counts <200cells/mm
3
, 200-500cells/mm
3 
and 
>500cells/mm
3
, the median for probing depth and clinical attachment level were higher in 
HIV patients with a CD4+T cell count >500cells/mm
3
 than those with CD4+T cell counts 
between 200-500 cells/mm
3
 and <200cells/mm
3
. 
 
Table.11 Spearman Rank Correlation 
                                                                                         
                   Plaque index        Gingival index         Probing depth      Clinical attachment level                                                
       
                                      
A rho            0.28149                   0.18813                      0.18842                       0.15461                            
     p               0.0018                     0.0396                       0.0393                         0.0918     
                              
  
B rho            -0.02748                  -0.03339                    0.09761                       0.12376 
       p              0.7657                    0.7173                       0.2889                         0.1781          
                                 
C rho             0.01514                  -0.01133                     0.18472                       0.20212    
      p               0.8696                    0.9023                       0.0434                          0.0268         
  
*A = Age of the study population                                    
*B = Grouped CD4+T cell counts  
*C = CD4+T cell counts 
*rho = coefficient of correlation 
*p = p value 
 
 
 
 
 
50 
 
5:5 Correlations between clinical indices with demographic and clinical variables  
5:5:1 Age of the population and clinical indices 
There was a statistically significant positive correlation between age and plaque index (p= 
0.0018), and gingival index (p= 0.0396) and probing depth (p= 0.0393). The correlations 
were 0.28149, 0.18813 and 0.18842 respectively. There was no significant correlation found 
between clinical attachment level and age at survey (Table.11). 
5:5:2 CD4+T cell counts and clinical indices 
There were positive correlations found between CD4+T cell counts with probing depth and 
clinical attachment level showing a significance of 0.0434 and 0.0268 respectively, but when 
the CD4+T cell counts were grouped, these correlations were no longer evident (Fig.3 and 
Table.11). Although, plaque and gingival indices respectively showed positive (0.01514) and 
negative (-0.01133) correlations with CD4+T cell counts (Table.11), no significant 
associations (as reflected in p values) were observed.  
 
Fig.3 Scatter plot showing correlation between CD4+T cell counts and clinical 
attachment level 
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5:6 BANA hydrolysis  
The BANA hydrolysis test was performed to detect the presence of periodontal pathogens 
referred to as “red complex” microorganisms. Of the 120 HIV-positive patients, 83 (69.2%) 
were reported as BANA-positive and 37 (30.9%) were BANA-negative (Tabe.12).  
 
Table.12 Frequency of BANA results 
Characteristics Frequency Percentage 
BANA positive 
BANA negative 
83 
37 
69.2% 
30.9% 
 
 
5:6:1 CD4+T cell counts and BANA  
 
There was no significant association found between BANA with CD4+T cell counts 
(Wilcoxon test, p= 0.7075). Significant positive correlations were found between BANA with 
clinical indices. The median for CD4+T cell counts in patients with positive BANA were 
higher than those who were BANA negative. The median for clinical indices of BANA-
positive patients were higher than for the BANA-negative patients, except for the gingival 
index where no marked difference was found for BANA-positive patients compared to 
BANA-negative patients. Table.13 shows no statistical significance result observed between 
CD4+T cell counts and with BANA test using Wilcoxon rank sum test. However, highly 
significant associations were observed between BANA and probing depth and clinical 
attachment level, while marginal significances were observed between BANA and plaque and 
gingival indices using Wilcoxon rank sum test. 
 
 
5:6:2 Grouped CD4+T cell counts and BANA 
 
No statistical significance observed between BANA with grouped CD4+T cell counts using 
Pearsons chi-square test (p= 0.9989) (Table.14). 
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Table.13 CD4+T cell counts and clinical indices relative to BANA 
                                                                          BANA 
                  Positive (N= 83)                         Negative (N= 37)  
Variables Mean(SD) Median Minimum-
Maximum 
Mean(SD) Median Minimum-
Maximum 
p 
value  
CD4+T 
cell counts 
299.07(157.16) 300 61-859 280.79(137.6) 256 36-562 0.7075 
Plaque 
index 
2.64(0.46) 2.9 1.3-3 2.35(0.64) 2.5 0.8-3 0.0248 
Gingival 
index 
2.83(0.35) 3 1.5-3 2.59(0.59) 2.9 0.5-3 0.0348 
Probing 
depth 
5.06(1.02) 5 2.9-6.8 4.12(0.76) 4 2.9-5.8 <.0001 
Clinical 
attachment 
level 
5.6(1.1) 5.9 3-7.3 4.59(0.83) 4.4 3-6.1 <.0001 
 
 
Table.14 Grouped CD4+T cell counts relative to BANA 
BANA Grouped CD4+T cell counts 
              (p= 0.9989) 
Total 
 
 <200 200-500 >500  
Negative 11(29.8%) 22(59.5%) 4(10.9%) 37(30.4%) 
Positive 25(30.2%) 49(59%) 9(10.9%) 83(69.2%) 
 
5:7 Associations between Oral hygiene and CD4+T cell counts  
Statistically significant differences were found between CD4+T cell counts relative to 
brushing and the use of interdental aids with p values of 0.0190 and 0.0170 respectively. A 
higher mean of 313.14 (152.63) was found in those who brushed once a day 84 (70%) 
compared to those who brushed twice a day 36 (30%) with a mean of 247.45 (138.6). 
Likewise, the majority of the population 94 (78.4%) never used interdental aids and a higher 
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mean of 310.6 (149.6) and a median of 308 was found between them compared to those who 
used interdental aids 26 (21.7%). Table.15 shows statistically significant results between 
CD4+T cell counts with brushing and interdental aids using Wilcoxon rank sum test 
Table.15 CD4+T cell counts relative to oral hygiene 
Variables N Mean (SD) Median Minimum-
Maximum 
p value 
Brushing 
frequency 
    0.0190 
Once a day 84(70%) 313.14(152.63) 312 61-859  
Twice a day 36(30%) 247.45(138.7) 213 36-700  
Interdental aids 
use 
    0.0170 
Yes 26(21.7%) 231.35(142.28) 211.5 36-700  
No 94(78.4%) 310.6(149.6) 308 90-859  
 
5:8 Associations between Oral hygiene and BANA  
 
5:8:1 BANA and the frequency of brushing 
 
Out of 83 (69.2%) BANA-positive patients 62 (74.8%) brushed once a day and about 21 
(25.4%) patients brushed twice a day (Table.16). Among 37 (30.9%) BANA-negative 
patients, 22 (59.5%) admitted brushing once a day and 15 (40.6%) patients admitted brushing 
twice a day. There were no statistical significant associations found between BANA and 
frequency of brushing using Pearsons chi-square test (p= 0.0925). 
 
Table.16 BANA relative to frequency of Brushing 
BANA      Brushing (p= 0.0925) Total 
                  Once a day Twice a day  
Negative 22(59.5%) 15(40.6%) 37(30.9%) 
Positive 62(74.8%) 21(25.4%) 83(69.2%) 
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5:8:2 BANA and the use of interdental aids 
 
Statistically significant association was found between BANA and the use of interdental aids 
(p= 0.0168). A majority of 70 (84.4%) of BANA-positive patients never used interdental aids 
while 13 (15.7%) of them reported using interdental aids. Among the BANA-negative 
patients, 24 (64.9%) never used interdental aids and 13 (35.2%) used interdental aids. 
Table.17 shows statistical significance results observed between BANA positivity with 
interdental aids using Pearsons chi-square test 
 
   Table.17 BANA relative to interdental use 
BANA      Interdental aids (p= 0.0168) Total 
 No Yes  
Negative 24(64.9%) 13(35.2%) 37(30.9%) 
Positive 70(84.4%) 13(15.7%) 83(69.2%) 
 
5:9 Associations between CD4+T cell counts and Smoking 
CD4+T cell counts (p=0.0540), plaque index (p= 0.0180), probing depth (p= 0.0191) and 
clinical attachment level (p= 0.0109) appeared to increase significantly relative to the 
smoking status of the study population. However there was no significant association found 
between gingival index and smoking, with the median for gingival index being similar for 
smokers and non-smokers. Table.18 shows statistically significant results observed towards 
CD4+T cell counts, plaque index, probing depth and clinical attachment level relative to 
smoking using Wilcoxon rank sum test (significance 0.01<p<0.05). 
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Table.18 CD4+T cell counts and clinical indices relative to smoking status 
                                                                           Smoking 
                  Yes (N= 60)                          No (N= 60)  
Variables Mean(SD) Median Minimum-
Maximum 
Mean(SD) Median Minimum-
Maximum 
p 
value 
CD4+T 
cell counts 
322.45(164.46) 312 61-859 264.4(131.4) 214 36-562 0.0540 
Plaque 
index 
2.66(0.49) 2.9 0.8-3 2.44(0.56) 2.55 1.2-3 0.0180 
Gingival 
index 
2.8(0.45) 3 0.5-3 2.70(0.45) 3 1.4-3 0.1500 
Probing 
depth 
4.99(0.9) 5 3-6.8 4.54(1.04) 4.15 2.9-6.4 0.0191 
Clinical 
attachment 
level 
5.55(1) 5.75 3.4-7.3 5.03(1.13) 5 3-7.1 0.0109 
 
5:10 Association between BANA and Smoking 
 
60% of the smokers and 40% of the non-smokers were BANA-negative. Among the BANA-
positive patients, 78.4% were smokers and 21.7% were non-smokers. A statistical 
significance was found between BANA positivity and smoking using Pearsons chi-square test 
(p= 0.0297) (Table.19). 
 
 
Table.19 BANA relative to smoking 
BANA  Smoking (p= 0.0297) Total  
 No Yes  
Negative 24(40%) 36(60%) 60(50%) 
Positive 13(21.7%) 47(78.4%) 60(50%) 
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5:11 Association between CD4+T cell counts and ART 
A highly significant positive relationship was found between CD4+T cell counts with ART 
(p=<.0001) (Table 20). The median for CD4+T cell counts of patients who were on ART 
were higher than those who were not on ART. Of the 47 (39.2%) patients who were without 
ART, 68.1% belonged to <200 CD4+T cell counts group, 29.8% belonged to 200-500 
CD4+T cell counts group and a few (2.2%) belonged to >500 CD4+T cell counts group. 
Among the 73 (60.9%) patients with ART, majority of the them (78.1%) belonged to 200-500 
CD4+T cell counts group and a few of 5.5% patients belonged to <200 CD4+T cell counts 
group.  Significant positive relationships were found between ART with probing depth (p= 
0.0065) and clinical attachment level (p= 0.0029) with a higher median than those who were 
not on ART. However there were no significant relationships found between ART with 
plaque and gingival indices and the median appeared similar to that of patients without ART. 
Table.20 shows highly statistical significance between CD4+T cell counts, probing depth and 
clinical attachment level with ART using Spearmans rank sum correlation test. 
 
Table.20 CD4+T cell counts and clinical indices relative to ART 
                                                                                  ART 
                 Yes (N= 73)                       No (N= 47)  
Variables Mean(SD) Median Minimum-
Maximum 
Mean(SD) Median Minimum-
Maximum 
Spearmans 
correlation 
(p value) 
CD4+T cell 
counts 
377.74(126.97) 352 140-859 162.47(70.67) 158 36-520 0.77004 
(<.001) 
Plaque  
Index 
2.58(0.53) 2.8 0.8-3 2.51(0.55) 2.8 1.3-3 0.03499 
(0.7044) 
Gingival 
index 
2.75(0.48) 3 0.5-3 2.76(0.4) 3 1.8-3 -0.01551 
(0.8665) 
Probing 
depth 
4.97(1) 5 2.9-6.8 4.45(1) 4 2.9-6.4 0.24716 
(0.0065) 
Clinical 
attachment 
level 
5.53(1.03) 5.6 3-7.3 4.92(1) 4.6 3-6.9 0.26956 
(0.0029) 
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5:12 Association between Grouped CD4+T cell counts and ART 
 
CD4+T cell count groups showed a highly significant relationship with ART (p= <.0001). A 
greater percentage of HIV-positive patients with ART had CD4+T cell counts between 200-
500 cells/mm
3
 and a major percentage of the patients with CD4+T cell count <200cells/mm
3
 
indicating severe immunosuppression were without ART. Statistical significance observed 
between grouped CD4+T cell counts with ART using Pearsons chi-square test (Table.21). 
 
Table.21 Grouped CD4+T cell counts relative to ART 
ART Grouped CD4+T cell counts 
              (p= <.0001) 
Total 
 
 <200 200-500 >500  
Negative 32(68.1%) 14(29.8%) 1(2.2%) 47(39.2%) 
Positive 4(5.5%) 57(78.1%) 12(16.5%) 73(60.9%) 
 
 
5:13 Association between BANA and ART 
 
There was no significant association found between BANA and ART (p= 0.8422). No 
statistical significance observed between BANA with ART using Pearsons chi-square test 
(Table.22). 
 
Table.22 ART relative to BANA 
BANA                  ART (p= 0.8422) Total 
              No Yes  
Negative 14(29.8%) 33(70.3%) 47(39.2%) 
Positive 23(31.6%) 50(68.5%) 73(60.9%) 
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6: DISCUSSION 
 
Much controversy continues to exist regarding the association between HIV infection and 
periodontal disease. Although some studies have demonstrated an increase in the severity and 
prevalence of periodontal diseases in HIV-positive populations (McKaig et al 1998 b; 
Masouredis et al, 1992; Riley, 1992; Drinkard et al, 1991), others have reported no 
differences between HIV-positive and HIV-negative patients in CD4+T cell counts and the 
clinical presentation of periodontal disease (Smith, 1995; Tomar et al, 1995; Scheutz, 1997; 
Matee, 1999; Mulligan et al, 2004).  Reports have indicated that low CD4+T cell counts and 
high viral loads resulted in severe periodontal and oral manifestations in HIV-infected 
patients and that a better prognosis could be obtained by reducing their viral load and 
restoring their immune system (Patton, 1999). 
.  
The present study evaluated the association of CD4+T lymphocyte cell counts and the “red 
complex” subgingival pathogens among HIV-positive patients with chronic inflammatory 
periodontal disease. The examination of the mesial aspect of the Ramfjord teeth in this study 
was considered to be useful in predicting the whole mouth periodontal status since they have 
frequently been used in epidemiology and prevalence studies (Silness and Roynstrand, 1988; 
Baelum et al, 1995; Mumghamba et al, 2004) and provided a standardized sample site for all 
subjects, whether diseased or not. A limitation of sampling diseased sights only, wherever in 
the mouth they may occur, may often not be a true reflection of what is actually taking place 
at a particular site at a particular time since different sites on the same tooth may present with 
different measurements, thus introducing a bias.  
 
The overall CD4+T lymphocyte mean level of the study population was 293.5cells/mm
3
 and 
the mean clinical attachment level was 5.29. Statistically significant positive relationships 
were found between CD4+T cell counts and probing depth (p= 0.0434) and clinical 
attachment level (p= 0.0268). This is contrary to other studies where one study reported an 
association between clinical attachment destruction but not probing depth with progressive 
HIV infection (Robinson et al, 1996 b) and another demonstrated no difference between the 
level of clinical attachment loss and probing depth in HIV-positive and HIV-negative women 
irrespective of their CD4+T cell counts and viral load (Alves, 2006).  
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In the present study, the mean gingival index score was 2.75 showing a high prevalence of 
gingival inflammation. Plaque and gingival indices showed no significant associations with 
CD4+T cell counts, although positive (rho= 0.01514, p= 0.8696) and negative (rho=               
-0.01133, p= 0.9023) relationships were demonstrated. Doshi et al (2008) observed an 
increase in the gingival bleeding, a predictor of severe gingival inflammation, with reduced 
CD4+T cell counts (<200cells/mm
3
), suggesting that CD4+T cells may be an important 
indicator for clinical aggravation of HIV infection. However, they too could not report a 
significant positive correlation of bleeding index with CD4+T cell counts (p = 0.14).  
 
In a longitudinal study including 33 HIV-positive patients,  Alpagot et al (2003) established 
an association between gingival crevicular fluid levels of interferon gamma (GCF IFN-
gamma) and periodontal clinical parameters (p= <0.001), revealing that sites with increased 
GCF IFN gamma levels carry a higher risk of periodontal disease progression.  
In a cross-sectional study, Tomar et al (1995) failed to determine an association between 
periodontal disease and CD4+T cell counts. Their cut-off point for CD4+T cell counts was 
<300cells/mm
3
; nor was a statistical association found between CD4+T lymphocyte levels 
with higher prevalence of chronic periodontitis in a Brazilian population (Goncalves et al, 
2005 a). The reasons for this variation in the findings may be due to the fact that the study 
excluded individuals with severe periodontal conditions and also because all of the 64 HIV-
positive Brazilian patients included, were on trimethoprim and sulfamethoxazole prophylaxis 
to prevent opportunistic infections, thus limiting the severity of periodontal disease. Findings 
by Howard (1991) considered periodontal disease as a later complication, rather than one of 
the first signs, of HIV infection. 
 
An interesting finding in the present study was that no significant associations were found 
between any of the periodontal indices and CD4+T cell counts when grouped into 
<200cells/mm
3
, 200-500cells/mm
3
 and >500cells/mm
3
. On the contrary, a study by Vastardis 
et al (2003) determined that for individuals with moderate or severe immunosupression 
(CD4+T cell count <500cells/mm
3
), a significant positive correlation existed between CD4+T 
cell counts with modified gingival index and bleeding index with a marginal significance for 
clinical attachment level (p= 0.0560), while individuals with extreme immunosupression 
(CD4+T cell count <200cells/mm
3
) showed less periodontal disease compared to those with 
higher CD4+T cell counts. In their study they could not find any significant association 
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between periodontal indices and CD4+T cell counts for all the individuals examined. 
Moreover a relatively small number of 39 patients were used in their study compared to the 
present study with the sample size of 120. 
 
As generally expected, the lower the immunosuppression of an individual, the higher the 
severity of periodontal disease detected. The present study revealed that a relationship existed 
between the immunosuppression of the individuals and their periodontal status. However, the 
stages of immunosuppression do not favour the severity of periodontal disease. The reason 
may possibly be due to the differences in the study groups and the method used to collect the 
periodontal data. The study population selected had moderate to severe forms of periodontal 
disease and the subgingival specimens were taken from the sites with maximum probing 
depths. The majority of individuals in the study had probing depths and clinical attachment 
levels >5mm, indicating a higher prevalence of periodontal disease. Both male and female 
patients were included in the study with the probable exception of pregnant patients and any 
patients with recent antibiotic therapy and dental treatment.  
 
BANA test was used to detect the presence of anaerobic infections caused by the subgingival 
pathogens Treponema denticola, Porphyromonas gingivalis and Tannerella forsythia. 
Although the test does not differentiate between the three species of bacteria in the plaque 
sample, it was considered that if any of the three “red complex” species was present, the 
BANA test would appear positive. The accuracy of the BANA test was established in a study 
by Bretz et al (1990) with BANA showing an accuracy of 93% for Treponema denticola, 
76% for Tannerella forsythia and 96% for Porphyromonas gingivalis compared with indirect 
immunofluorescent antibody techniques. In this study, BANA test showed significant 
associations with all the periodontal indices, with clinical attachment and probing depth 
measurements demonstrating a highly significant (p= <.001) association, while lower levels 
of significance were found between plaque (p= 0.0248) and gingival (p= 0.038) indices and 
BANA. This investigation’s results clearly indicate the ability of BANA positive species to 
cause periodontal disease manifestations. Similar results suggesting an association between 
BANA and clinical signs of periodontal disease have been reported (Grisi et al, 2001; 
Figueiredo et al, 2000).  Findings by Loesche et al (1987); Bretz et al (1989); Socransky et al 
(1998) and Schmidt et al (1988) showed a strong correlation between BANA and increasing 
probing pocket depth, while  a high frequency of BANA positive results (66.1%) was found 
even at a minimum pocket depth of 2 to 3mm, with a significant correlation between gingival 
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index and BANA, based on the presence or absence of bleeding on probing, thus 
demonstrating that gingival changes even at a small pocket depth may indicate colonization 
by BANA positive microorganisms (Grisi et al, 1998).   
 
There were significant positive relationships found between gingival index (p= 0.0396) and 
probing depth (p= 0.0393) with the age of the HIV-positive population. Plaque index showed 
a highly significant (p= 0.0018) positive relationship with age. The study group aged between 
17-55 years. This growing age of the study population may support the fact that as the person 
gets older the chances of developing periodontal disease manifestations among them are high. 
Likewise, a study conducted by Taani et al (2003) also reported a significant association 
between the increase of age and probing depth. Martinez-Canut et al (1995) established a 
statistical significance between age and periodontitis. Since probing depth was directly 
related to age and BANA positive tests, this study may correlate with the studies of 
Rodenburg et al (1990), Savitt and Kent (1991) and Yoshihiko et al (2000) who reported age 
as one of the risk factors for Porphyromonas gingivalis infection. Yalcin et al (2002) reported 
no association between age and clinical parameters.  
 
A study of 61 adult patients with gingivitis or periodontitis, demonstrated a statistical 
correlation with the severity of periodontal destruction and BANA but failed to determine a 
statistical correlation between plaque index and BANA (Puscasu et al, 2006). However their 
study used both supragingival and subgingival plaque deposits for BANA, thus accounting 
for the lack of correlation with plaque index since less anaerobic bacteria would be detected 
in supragingival than in subgingival plaque. However, in the present study, only subgingival 
plaque samples were collected, thus detecting the “red complex”, where they colonise 
abundantly. About 30.83% patients showed BANA negative results. As earlier stated, BANA 
negative plaques may also influence changes in periodontal disease activity even though they 
remain below the detection limit of the BANA test.  
 
The oral hygiene behaviours as explained by the frequent brushing habits and the use of 
interdental aids, as additional cleaning devices to clean the teeth, were significantly related to 
CD4+T cell counts of the patients. Most of the HIV patients examined, brushed only once a 
day (70%) and never used interdental aids (78.33%). This indicates less effort on the patient’s 
part to maintain better oral hygiene, ultimately leading to gingival inflammation and 
periodontal diseases. The frequency of brushing was significantly associated with plaque 
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index (p= 0.0352) and not with the other periodontal indices. However, the use of interdental 
aids showed significant associations with all of the periodontal indices except the probing 
depth. Inadequate oral hygiene can be considered as a risk indicator, risk factor, and/or risk 
predictor in the development of periodontal manifestations (Bakdash, 1994) which may be 
exacerbated by HIV infection. 
 
As one would expect, more frequent brushing and interdental use tends to provide better 
plaque control and improved gingival health. Microbial plaque is reduced in the mouths of 
individuals with good oral hygiene. A knowledge about the living and educational 
background of the study population was important in order to understand their interest in 
maintaining good oral hygiene which was mandatory for their general health. The majority of 
patients in the study population had a minimum level of education with better living 
conditions. However, less interest was seen among them in maintaining better oral health.   
 
Overall, the oral hygiene status among the individuals was poor. A large part of the patients 
brushed only once a day instead of brushing twice a day and never used interdental aids to 
keep their teeth clean. However, only 10.83% of them managed regular dental visits. Many of 
the patients were not aware of the fact that their oral health may have a huge impact on their 
medical health. Lack of proper oral hygiene may lead to the accumulation of periodontal 
microorganisms in the mouth resulting in a positive response to the BANA test. Although 
BANA was not significantly related to the frequency of brushing (p= 0.0925), there was a 
significant relationship between BANA and the use of interdental aids (p= 0.01). The 
immmunosuppression of HIV patients influences the prevalence of periodontal diseases 
which in turn is exacerbated by their poor oral hygiene. 
 
The association between CD4+T cell counts with periodontal measures may be influenced by 
other factors. For instance, it was found that cigarette smoking, showed a significant 
association with CD4+T cell counts (p = 0.0540). The plaque index (p = 0.0180), probing 
depth (p = 0.0191) and clinical attachment level (p= 0.0109) scores of the HIV patients 
examined, were also significantly related to their smoking habits, except for their gingival 
index scores (p= 0.150). Hence the present study established that smoking is a true risk factor 
for periodontal disease as was found in previous studies (Bergström and Preber, 1994; Tomar 
et al, 1995; AAP, 1996 c; Barbour et al, 1997) with smokers demonstrating a higher 
susceptibility to advanced and aggressive forms of periodontitis than non-smokers (Calsina et 
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al, 2002). A comparison of seropositive and seronegative patients revealed higher scores of 
gingival index and probing depth in seropositive individuals (Ndiaye et al, 1997) and in 
individuals using smokeless tobacco compared to the non-tobacco control subjects (Poore et 
al, 1995). 
 
A significant correlation was also established in the present study between smoking and 
BANA positivity (p= 0.0297) in HIV-positive individuals. Other studies reported that 
smokers have 10 times more BANA positive plaques than non-smokers (Zambon 1996 a; 
Kazor et al, 1999) with a statistically significant correlation in smokers with deep pockets (p 
= 0.02) and shallow pockets (p = 0.0002) when compared with non-smokers (Theagarayan et 
al, 2010). When examining for members of the red complex, dental plaque in smokers 
showed higher levels of Tannerella forsythia (Zambon et al, 1996 b; Kazor et al, 1999),   
Aggregatibacter actinomycetemcomitans and Porphyromonas gingivalis compared to non-
smokers (Kazor et al, 1999).  On the contrary, a study by Bostr m et al (2001) used 
checkerboard DNA-DNA hybridization technology, to demonstrate that smoking exerts little, 
if any, influence on the periodontally associated subgingival pathogens including the “red 
complex”. Hence the present study agrees with these studies which confirm the use of BANA 
as a rapid chair-side diagnostic test for the detection of the “red complex” microbiota 
(Andrade et al, 2010; Loesche et al, 1992).  BANA was not found to be correlated with total 
CD4+T cell counts nor with grouped CD4+T cell counts in the present study. 
 
A highly significant association was found between ART with both total CD4+T cell counts 
and CD4+T cell counts categorized into groups (p= <.0001). A large percentage of the 
individuals without ART suffered with severe immunosuppression (<200 cells/mm
3
). This 
clinical finding confirms that antiretroviral therapy in HIV-positive patients has a strong 
effect on their immune system and unlike patients on ART who demonstrate an increase in 
their CD4+T cell counts; these patients show evidence of being severely immunosuppressed.  
As in the study by Smith et al (2004), the majority of patients in the present study showed 
higher CD4+T cell counts as a result of undergoing long-term antiretroviral therapy.  Not all 
the patients who participated in this study were on ART or any other form of antimicrobials.  
This may have contributed to their higher prevalence of periodontal disease. It can be 
suggested that an early introduction of HIV patients with CD4+T cell counts <200cells/mm
3
 
to ART may limit their exposure to immunosuppression and periodontal disease.  
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In the present study, ART showed significant relationships with probing depth and clinical 
attachment level but not with the plaque and gingival indices. The patient compliance with 
ART, besides being positive for the virus, was thought to determine the severity of 
periodontal destruction. A study by Vernon et al (2009) including 112 HIV-positive adults on 
HAART, reported a significant association between CD4+T cell counts <200 cells/mm
3
 and 
higher levels of clinical attachment loss and periodontal pathogens thus proposing 
periodontal disease as a deadly challenge to the long-term oral health of HIV-infected 
individuals. Few studies have reported on the effectiveness of HAART and the reduced 
incidence of oral damage (Mulligan et al, 2004; Greenspan et al, 2004). Some studies have 
claimed that HAART reduces the incidence of HIV-related oral manifestations (Patton et al, 
2000 b; Hardy et al, 2002; Nicolatou-Galitis et al, 2004), while yet others demonstrated no 
correlation between CD4+T cell count and ART duration with probing depth and suggested 
that these immune factors appeared to have less impact on acute periodontal disease (Beck 
and Offenbacher, 2002).  
 
No significant association was found between BANA and ART (p= 0.8422). This observation 
can be supported by the study conducted by Botero et al (2007 b) establishing that ART has 
no effect on the composition of subgingival microbiota in HIV patients with periodontal 
disease. Moreover there was no association found between BANA and CD4+T cell counts in 
the HIV-positive patients in the study which could explain the lack of any association 
between BANA and ART.  
 
As discussed earlier, the subgingival microbiota in periodontal disease consists of a pool of 
several microorganisms coaggregating with each other in the establishment of a pathogenic 
community facilitating the progression of periodontal inflammation. Since the current 
investigation was strictly restricted for the detection of “red complex” subgingival pathogens 
only, knowledge of the relation with one or a combination of other periodontopathic bacteria 
causing destruction of the periodontium cannot be ignored. This could be considered as a 
limitation of the study since other bacterial species that might have been present 
subgingivally were not detected. The virulence factors of the “red complex” species in 
synergy with other oral bacteria should be considered pathogenic.  
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CONCLUSION 
 
To conclude, the above study establishes an association between CD4+T lymphocyte levels 
and periodontal disease indices in HIV-positive patients. The clinical signs and symptoms of 
gingival and periodontal disease with reduced CD4+T cell counts remain as a significant 
complication of HIV infection. This shows the importance of higher periodic clinical control 
to prevent these periodontal manifestations. Long term ART greatly reduces the exposure to 
immunosuppression and also to some extent may reduce the incidence of periodontal disease. 
 
Special attention to the presence of Gram-negative bacteria is essential. BANA has proved to 
be effective in the early diagnosis of periodontal disease. In the present study, the “red 
complex” subgingival pathogens were closely related to the clinical parameters of 
inflammation and periodontal destruction and appear meaningful in periodontal diagnosis. 
However, the presence of the “red complex” pathogens were not associated with the 
immunosuppression of the HIV-positive patients. A positive BANA test after the regular 
maintenance program indicates the repopulation of these bacteria subgingivally. Therefore, it 
further helps the clinician to monitor the periodontal disease progress. The BANA test also 
helps to determine the diseased sites that require any form of periodontal treatment. 
 
Oral hygiene maintenance and smoking habits appeared to be strongly related to periodontal 
disease, forming risk factors for gingivitis and periodontitis. A greater emphasis on oral 
health and prevention of periodontal disease is necessary especially among HIV-infected 
individuals. Comprehensive dental care should be advised to all the immunosuppressed HIV 
patients especially those who neglect their oral health.  
 
Therefore, this study determined an association between CD4+T lymphocyte cell counts and 
periodontal disease progression in HIV-positive patients. Although, “red” complex pathogens 
were detected by the BANA test in HIV-positive patients with indicators of periodontal 
disease, no association was dertermined between the “red” complex pathogens and CD4+T 
lymphocyte cell counts or immunosuppression in these patients. . 
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                                                             APPENDIX 4:2 A 
 
                    CONSENT FORM FOR PARTICIPATION IN RESEARCH PROJECT 
 
Title of Project: Association of CD4+T lymphocyte levels and “red” complex pathogens of 
chronic inflammatory periodontal disease in HIV-positive patients 
Names of Researchers: Dr. Cathy Nisha John, Prof. LXG Stephen, Prof CWJ Africa 
If you would like to participate in this study please tick the relevant boxes: 
1. Have you read the attached information sheet and has the purpose of the research 
       project been explained to you?      Yes or No 
 
2. Do you understand the method of sample collection and any risks involved? 
Yes or No 
 
3. Do you grant permission for information from your medical records to be disclosed 
       to the research team as and when necessary?   Yes or No 
 
4. Do you agree that samples collected for research or diagnostic testing can be stored for 
      possible use in future research projects conducted by the above named researchers 
      and /or other research collaborators?  Yes or No 
I declare that my participation in this research is voluntary and that I am free to withdraw my 
approval for use of the sample(s) at any time without my medical treatment or legal rights 
being affected. I understand that any information contained in my file will remain 
confidential and that I or my doctor will be informed if any of the results of the medical tests 
done (as part of the research) have implications for my health. I know how to contact 
members of the research team should I change my mind about participating in this study. 
……………………………                           ……………….                          ………………… 
Name of patient                                                   Date                                         Signature 
(BLOCK CAPITALS) 
……………………………                           ………………                           …....…………… 
Name of person taking consent                         Date                                         Signature               
…………………………                               ………………                           ………………… 
Name of researcher                                            Date                                          Signature 
THANK YOU FOR AGREEING TO PARTICIPATE IN THIS RESEARCH 
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                                                        APPENDIX 4:2 B                                    
Office of the Deputy Dean 
Postgraduate Studies and Research    
Faculty of Dentistry & WHO Collaborating Centre for Oral Health 
 
 
                                                   UNIVERSITY OF THE WESTERN CAPE 
                                                     Private Bag X1, Tygerberg 7505 
                    SOUTH AFRICA                  
                                                                                          Date: 20th July 2011 
 
For Attention: Dr CN John 
Department of Oral Medicine and Periodontology 
Dear Dr John 
 
STUDY PROJECT: Association of CD4+ T lymphocytes levels and “RED” complex pathogens 
of chronic periodontal diseases in HIV positive patients  
PROJECT REGISTRATION NUMBER: 11/5/19 
ETHICS: Approved 
 
At a meeting of the Senate Research Committee held on Friday 10th June 2011 the 
above project was approved. This project is therefore now registered and you can 
proceed with the work. Please quote the above-mentioned project title and 
registration number in all further correspondence. Please carefully read the 
Standards and Guidance for Researchers below before carrying out your study. 
 
Patients participating in a research project at the Tygerberg and Mitchells Plain 
Oral Health Centres will not be treated free of charge as the Provincial 
Administration of the Western Cape does not support research financially. 
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Due to the heavy workload auxiliary staff of the Oral Health Centres cannot offer 
assistance with research projects. 
 
Yours sincerely 
 
 
 
 
Professor Sudeshni Naidoo    
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                                                     APPENDIX 4:2 C 
INFORMATION SHEET 
Prospective participants are requested to read this information sheet carefully and to 
ask questions where necessary, before signing the attached consent form. This sheet 
must be detached and retained by the participant and the consent form filed for record. 
Evidence has related the progression of HIV infection and the severity of periodontal 
inflammation and subsequent destruction of the periodontium. Based on the risk assessment, 
HIV infection is a risk indicator that increases the susceptibility to periodontal diseases. HIV 
infection results in gradual loss of immunologic functions, especially those mediated by 
CD4+T helper cells with consequent impairment of immune response leading to severe 
periodontal conditions. The bacterial species associated with periodontal disease are located 
within the dental plaque or oral biofilm both above and below the gum margins. Therefore, 
the purpose of this study is to investigate the presence of subgingival periodontal pathogens 
in HIV positive patients, with chronic inflammatory periodontal disease at various CD4+T 
lymphocyte levels and to shed light on its association with periodontal disease progression. 
The clinical procedure will entail the measurement of oral clinical indices for use in making a 
clinical diagnosis of periodontal disease and the removal of plaque samples from the selected 
teeth to investigate the presence of periodontal pathogens. The clinical measurements and 
sample collection are non-invasive and safe and will be carried out with the utmost care to 
ensure the comfort of the patient. 
 
Patients will be required to sign the attached form granting consent for these procedures to be 
carried out and for the subsequent use of the samples donated and clinical parameters 
recorded. The patient will also be required to grant permission for her HIV status and other 
medical history to be disclosed. Participants will not be recorded by name, but samples and 
information will be coded to protect the identity of the individual. However, the coding will 
be used by the clinic to trace the individual if relevant information (as a result of the study) 
should be passed to her or her doctor. Where necessary, participants with severe periodontal 
disease will be referred for treatment. Permission will also be sought for the use of additional 
biological material collected in the clinic, which is usually discarded but which the 
researchers may find useful for future research. 
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Participation in this study is voluntary and refusal to participate will not prejudice the 
treatment of the patient in any way. Consent to participate will be recorded by completing the 
attached form. Should individuals agree to participate and later change their minds, they may 
withdraw by calling the following persons: 
Prof LXG. Stephen, Department of Periodontics and Oral Medicine, University of the 
Western Cape, Tel: 021 9373131, or Prof CWJ. Africa, Department of Medical Biosciences, 
University of the Western Cape, Tel: 021 9592341, or Dr Cathy Nisha John, Tygerberg 
dental hospital, Tel: 021 9373167. 
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                                                            APPENDIX 4:2 D 
Health Risk Assessment Questionnaire 
Dear patient, 
As part of this study we need to collect information pertaining to your lifestyle so that an 
assessment of your health risks may be made. Any information contained on this sheet will be 
held in the strictest confidence and I would urge you to respond to the questions with 
accuracy. No details of personal identification will be included for your protection. 
Age (yrs)………..                                                         Gender (M/F)……… 
Race (White/ black/ coloured/others)…………. 
1. What is your level of formal education? 
High school/ Primary school/ University/ No 
formal education 
2. Do you live in a house?  
Flat/ Shack/ House 
3. How many people share your home? 4. How long have you been living at your present 
address?  <5years, 5-10years, >10years 
5. (i) Have you ever had a sexually 
transmitted disease? Yes/No 
(ii)If yes, do you know what it was and was it 
treated? 
6. How long have you been diagnosed with HIV 
infection?  
Days…../ Months….../ Years……. 
 
7. (i) Are you being treated with 
antiretroviral drugs?   Yes/No 
(ii) If yes, what is the duration of the 
treatment? 
8. (i) How frequently do you visit a dentist? 
Never/ Once a year/ Twice a year/ Whenever 
(ii)When was the last time you visited a dentist? 
(iii)Do your gums bleed when you brush your teeth?           
Yes/No 
(iv)How frequently do you brush your teeth? 
Once a day/ Twice a day/ After every meal 
(v)Do you use any interdental aids? Yes/No 
9. (i) Do you smoke?  Yes/No/Sometimes 
(ii)If yes, how many a day? <5/ 5-10/ >10 
(iii)How long have you been smoking?   
<5years/ 5-10years/ >10years 
 
10. What does your diet mainly consist of ? 
Bread/ Meat/ Fruit and Veg 
Thank you for your participation 
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                                                APPENDIX 4:7:1 E 
                                               CLINICAL MEASUREMENTS 
 
Patient number: ……………………            Date of examination: ……………………                  
Date of Birth: ……………………..             CD4+T cell count: …………………….  
  
 16m 21m 24m 36m 41m 44m 
PI       
GI       
PD       
CAL       
BANA       
Observations 
…………………………………………………………………………………………………
…………………………………………………………………………………………………
………………………………………………………………………………………………… 
 
Examiner………………………… 
Assisted by………………………. 
 
 
 
 
 
 
 
 
 
 
 
